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CHAPTER I 
INTRODUCTION 
An agent of biological origin endowed with the 
specific capacity of accelerating the mobilization of depot 
fat was described by Best and Campbell (1936) as occurring 
in the anterior pituitary gland. This adipokinin (adipo-
kinetic substance) concentrated from aqueous extracts of 
beef anterior pituitary glands by precipitation, at pH 5.2, 
with 2 volumes of alcohol, upon injection into the fasted 
mouse produced an increase in the quantity of liver fat 
which was, within limits, linearly related to the dose 
injected; moreover, it accelerated the mobilization of 
depot fat and caused ketonemia. Weil and Stetten (1947), 
entertaining that variations might occur in the quantity 
of adipokinetic substance released under conditions of 
starvation or diabetes that might, in turn, be reflected by 
variations in an analogous activity in the urine, used a 
similar extraction procedure and were the first to show 
that lipid mobilizing activity could be demonstrated in the 
urine during fasting. These authors found that an alkaline 
extract of urine from fasting rabbits when injected into 
mice caused an increase in liver fat. Similarly prepared 
extracts of urine from fed rabbits had no such effect. 
Concurrently, it is still given to speculation, whether the 
1 
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adipokinetic activity demonstrated to occur in the urine 
of the fasted rabbit is identical with that shown by Best 
and Campbell (1936) to occur in the normal anterior pitui-
tary gland. However, during fasting and under conditions 
in which an increase in the mobilization of depot fat might 
be anticipated, there appears in the urine a material 
capable of provoking such an increase, which at leastsuper-
ficially resembles pituitary adipokinin (Weil and Stetten, 
1947). 
Chalmers et al. (1958) extended these observations to 
humans, based on studies on obese individuals. It appeared 
that a mechanism existed for controlling the mobilization of 
depot fat which must be sensitive to changes in the composi-
tion as well as the caloric content of the diet. Such a 
mechanism should be operating at its maximum during fasting, 
and if any hormonal agent were involved it should be detect-
able in the urine (Chalmers et al., 1958). 
Therefore, Chalmers et al. (1958) studied the effect 
on fat metabolism of urine collected from healthy people 
during periods of fasting. Subjects were fasted for thirty-
six hours. From the urine collected during the last twenty-
four hours of this period, a fat-mobilizing material could 
be precipitated at pH 5.3 with two volumes of ethanol. 
Subsequent separation, and extraction of the material with 
dilute sodium carbonate solution resulted in an alkaline 
extract which, upon injection into mice, produced an increase 
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in liver fat. Animals receiving the urine extracts from the 
same subjects on a normal diet, without fasting, had liver 
fat values very similar to those found in saline-injected 
animals. 
When the dose of fasting urine extract was varied by 
Chalmers (1960a) the increase in liver fat was found to be 
linearly related to the log dose. For convenience, the 
active material was referred to as Fat Mobilizing Substance 
(F.r-·IS) (Chalmers, 1965) • 
Further details of the characteristics of FMS were 
reported by the same authors and they postulated that FMS 
mobilizes fatty acids from adipose tissue by directly aug-
menting the lipolytic reaction. FMS activity did not appear 
in the urine of fasted hypophysectomized man or goat and 
Chalmers et al. (1960a) concluded that the pituitary (or 
adjacent hypothalamus) was necessary for its production. 
Comparison of FMS to known lipolytic substances of pituitary 
origin reveals important differences and Fl'!S does not appear 
to be any of those lipolytic substances (Chalmers, 1965). 
Following the extraction of FMS from the urine of 
fasting man, Stevenson et al. (1964) reported the extraction 
of a similar material (FMS I) by essentially the same proce-
dure from the urine of fasting rats that also showed fat 
mobilizing and hypoglycemic properties in vitro and in vivo. 
FMS extracted from the urine of fasting rats caused an 
increase in release of free fatty acids from rat epididymal 
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fat pads in vitro and upon injection into intact rats pro-
duced a weight loss, transient hypoglycemia, hyperlipemia, 
and an increase in fatty acid content of the liver. FMS I 
differed from the material isolated by Chalmers et al. in 
that a single subcutaneous injection in the rat caused a 
transient but pronounced decrease in food intake. Beaton et 
al. (1964) fractionated FMS I into FMS IA and FMS IB on the 
basis of solubility in alkaline and water solutions. These 
two fractions were chemically distinct, the anorexigenic 
property of FI-1S I was attributable to the IA component and 
the fat mobilizing property to the IB component. FMS acti-
vity was also detected in the urine of fasting mice, dogs, 
sheep, goats and horses (~ekwick et al., 1967) but little 
information has been reported on the nature of these fat-
mobilizing materials. 
FMS has also been extracted from the urine of fasting 
chickens (Nir et al., 1969). The method used to extract FMS 
was essentially that of Chalmers et al. (1958) as modified 
by Stevenson et al. (1964) and Beaton et al. (1964). 
Dietary Aspects and Application of Stress in Conditions in 
which FMS Activity is Found 
FMS activity can be detected in human urine after 
about 12 hours of fasting (Chalmers, 1965). Low-calorie 
diets also elicit activity provided they contain little 
carbohydrate (Chalmers et al., 1960a). It disappears when 
caloric intake is adequate for maintenance, but reappears 
5 
during caloric deprivation (Gordon, 1970). On normal unre-
stricted diets, or low-calorie high-carbohydrate diets, ac-
tivity is absent (Chalmers et al., 1960a). It seems to be 
most closely related to carbohydrate intake since dietary 
reduction of this specific nutrient will cause FMS to appear 
in the urine. In the human, a critical intake of 80 grams 
of carbohydate daily is needed to prevent its appearance 
(Gordon, 1970). 
However, as noted by Kekwick and Pawan (1967), patients 
who have had a pituitary ablation for carcinomatosis and who 
have been fasted or deprived of carbohydrates are unable to 
produce detectable amounts of FMS in the urine (Chalmers et 
al., 1960a). Chalmers et al. (1960a) observed no detectable 
fat mobilizing or ketogenic activity in the urine in 
patients with well-established pituitary deficiency receiv-
ing cortisone and thyroid in replacement dosage or in condi-
tions of severe carbohydrate restriction or fasting up to 36 
hours. Kekwick and Pawan (1967) reported that no activity 
could be detected in hypophysectomized fasting goats, as in 
human subjects with abnormal or absent pituitaries. An in-
tact pituitary gland appears necessary for the production of 
FMS. 
The effect of progressive restriction of dietary car-
bohydrate was studied in an obese patient (Chalmers et al., 
1960a). Urine was collected on the last two-days of each 
four-day dietary period. Diets provided on thousand cal-
ories of which one hundred were in the form of protein. 
6 
At first, when carbohydrate provided ninety percent of the 
remaining calories and fat only ten percent, no ketogenic 
activity could be detected in the urine. Activity began to 
appear when the proportion of calories provided by carbohy-
drate was reduced to half, and it increased progressively 
with further carbohydrate restriction. This relationship 
holds true when the diets are given in the reverse order 
(Chalmers, 1965). 
In very obese patients fasting and low carbohydrate 
diets appear to elicit a smaller output of FMS than in non-
obese subjects (Chalmers, 1965), presenting the possibility 
that a primary defect of its availability plays a part in 
the development of obesity. However, the fasted hypothala-
mic obese rat excretes a greater amount of FMS of increased 
specific and total activities than does the control animal, 
regardless of whether laboratory chow or a high-fat diet is 
fed and with increased excretion when a high-fat diet is 
fed prior to fasting as opposed to a diet composed of high 
carbohydrate (Beaton et al., 1966). Beaton et al. (1966} 
stated that since these animals have increased lipogenesis, 
a net increase in body fat, and excrete approximately twice 
as much FMS during fasting as do controls, their ability to 
produce and excrete a substance for mobilization of fat 
appears not to be impaired. However, adipose tissue taken 
from hypothalmic obese rats has a reduced response to FMS 
(Beaton et al., 1966a). Beaton et al. (1966a) noted the gain 
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of body fat in these animals may be due to an increased food 
·intake and lipogenesis, enhanced by a reduced response of 
their adipose tissue to one or more lipolytic agents. 
In the absence of dietary restriction no activity has 
been detected in late pregnancy, nor after short periods of 
exercise (Chalmers et al., 1960a). A totally adrenalecto-
mized patient found to have a corticotrophin secreting pitu-
itary tumor did not excrete FMS while on an unrestricted 
diet but responded normally to carbohydrate deprivation 
(Chalmers, 1965). Chalmers (1965) cited that this observa-
tion supports the view that FMS is not corticotrophin-depen-
dent and shows that functioning adrenal glands are not 
required for the production of activity in response to 
restriction of carbohydrate intake. 
In a number of clinical situations FMS has been de-
tected in the urine when carbohydrate intake was not severe-
ly restricted. Activity has been found in diabetic ketosis, 
in widespread malignant disease with wasting, and in the 
first few days after surgical operations (Chalmers, 1965), 
but in all cases the caloric intake was low (Chalmers et aL, 
1960a). Goth et al. (1965) confirmed the presence of FMS in 
the urine of patients with diabetes. In contrast, alloxan-
diabetic rats excrete less total activity of FMS than do 
control animals (Beaton et al., 1966). No abnormal activity 
was found in a patient with lipodystrophy (Chalmers et al., 
1960a), but in patients with diffuse lipoatrophic diabetes 
8 
consumption of an unrestricted diet failed to suppress uri-
nary activity (Chalmers 1960a; Louis et al., 1960, 1962). 
Chalmers (1965) noted that in one of two thyrotoxic patients 
activity was present which disappeared during treatment with 
carbimazole and therefore could not be attributed to TSH. 
Chalmers (1965) detected activity in three out of seven 
patients v.rith acromegaly on normal unrestricted diets which 
ceased shortly after pituitary implantation in two patients. 
FMS levels produced by altering the qualitative compo-
sition of isocaloric 1000 kcal diets in obese persons are in 
agreement with earlier suggestions by Kekwick and Pawan 
(1956 and 1957), that low carbohydrate diets are more effec-
tive in producing mobilization and loss of body fat than 
isocaloric diets high in carbohydrate (Pawan, 1971). More-
over, a high-fat low calorie diet produced higher FMS levels 
in obese subjects than an isocaloric diet high in protein. 
Chalmers et al. (1960) detected no FHS in the urine of 
humans subsisting on a calorically restricted diet composed 
largely of carbohydrate. Beaton et al. (1965) investigated 
the effects of previous diet on the excretion of FMS in the 
urine of fasting rats. Of four diets (high carbohydrate, 
high protein, high fat, and high protein-high fat) the 
greatest excretion of FMS was observed when the highprotein-
high fat diet was fed ad libitum prior to fasting. Dietary 
protein had no significant effect upon FMS excretion. Ex-
cretion of FMS was increased by prior feeding of a high fat 
9 
diet and decreased by feeding of a high-carbohydrate diet. 
The greatest total activity excreted per twenty-four hours 
was obtained with the diet highest in noncarbohydrate calo-
ries. Kwok (1974) observed the effects of four diets (high 
carbohydrate, high fat, noncarbohydrate-high fat, and high 
protein) on the excretion of FMS in the urine of rats fasted 
for 24 hours at 15°C. The rats were fed ad libitum 7 days 
prior to their fast under cold stress. Kowk (1974) indicated 
that a positive correlation exists between the lipolytic 
potency of crude FMS and the proportion of calories from fat 
in the diet. 
Previous dietary treatment can significantly affect 
the response of adipose tissue to FMS (Beaton et al., 1966a). 
Previous feeding of a high protein diet or noncarbohydrate-
high fat diet inhibits the lipolytic response in vitro of 
adipose tissue to FMS. The release of free fatty acids was 
greatest with the high-carbohydrate and high fat diets. The 
release of free fatty acids in the absence of FMS was non-
significantly different with the tissue obtained from rats 
fed the high carbohydrate, high fat, and noncarbohydrate-
high fat diets. Kwok (1974) showed that rats fed a high 
carbohydrate diet prior to 72 hours starvation at 0° to 5°C 
before sacrifice would provide epididymal fat tissue with 
maximum response to FMS. 
Karninen et al. (1962) reported results that suggest 
less activity may be excreted by humans in the second day of 
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fasting than on the first day. Chalmers (1965) stated that 
this report is in conflict with unpublished data from his 
laboratory showing a progressive increase in urinary activity 
in two lean subjects given a low-calorie, low-carbohydrate 
diet for 5 days. Pawan's (1971) observations compare favor-
ably with that of Chalmers (1965). During a 36-hour fast in 
normal subjects FMS levels progressively increased with time, 
but upon resumption of normal eating, FMS output decreased 
and was absent by the eighteenth hour after re-feeding. Pr~ 
longing the period.of fasting of obese persons produced an 
increase in FMS output from day 1 to day 5 of the fast, but 
by day 10 of the fast the FHS levels had again decreased 
(Pawan, 1971). Kekwick and Pawan (1967) observed in five 
female obese subjects that upon prolonged starvation FMS 
levels were virtually negligible by the fourteenth day. 
Crisp et al. (1968) have observed in subjects with primary 
anorexia nervosa of some duration who exhibited considerable 
fat loss, that FMS was undetectable in some cases, but on 
refeeding these persons, F~1S reappeared transiently, for a 
few days, and then again disappeared as re-feeding continued 
(Pawan, 1971). Crisp et al. (1968) and Pawan (1971) stated 
that starvation, a povJerful stimulus for F~1S production, if 
continued without nutrient intake, might cause temporary 
exhaustion of the secretory cells. 
Beaton et al. (1966) reported observations on the 
duration of fasting on excretion of lipid-nobilizing acti-
ll 
vity in the urine of rats. During fasting at 24°c the great-
est excretion of specific and total activities occurred in 
the first twenty-four hours and diminished thereafter up to 
seventy-two hours. Beaton (1966) noted that the sudden 
increase of excreted activity may be related to the coinci-
dent mobilization of fat in these animals during fasting 
and that decreased activity during prolonged fasting could 
possibly be due to decreased production or secretion of F~1S. 
The observations by Kwok (1974) compare favorably with those 
of Beaton et al. (1966). With fasting, there was appreciable 
excretion of active FMS, the excreted specific activity being 
greatest in the first 24 hour fasting period and diminishing 
thereafter. Kwok (1974) in agreement with Beaton et al. 
(1966) stated that the sudden increase of excreted activity 
may be related to the coincident mobilization of fat in the 
rat during fasting, noting the frequent observation that in 
situations in \vhich the mobilization of fat from depots is 
known to occur, there is an increased excretion of FMS. 
Mobilization of fat during acute exposure to cold 
stress is known to occur, presumably in response to the 
increased demand for energy. The urinary excretion of a 
fat-mobilizing·substance by rabbits during exposure to cold 
has been reported by Braun and Mosinger (1961) . Observa-
tions by Beaton et al. (l964a) showed that FMS is not ex-
creted by rats during feeding at an ambient temperature but 
is excreted by fed rats during acute exposure to cold of an 
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environmental temperature of S°C. Stevenson et al. (196S) 
observed a progressively increasing excretion of FMS in the 
urine of fasting rats with decreasing environmental tempera-
ture from 30° to S0 c. Kwok (1974), upon decreasing the en-
vironmental temperature from 30° to S°C observed a progres-
sive increase in the excretion of crude FMS to a maximum at 
1S°C and expressed the opinion that it may well be that in-
creased spontaneous activity (exercise) or shivering is the 
causative factor in increased excretion of FMS at about 1S0 
c. Exercise has been reported by Basu et al. (1960) to in-
crease serum concentration of free fatty acids, an index of 
fat mobilization. 
Sex, Age, Metabolic Obesity and Weight Reduction 
Pawan (1971) studied the effect of age on the produc-
tion of FMS in normal persons fasted for 36 hours. Adult 
human subjects, forty years of age produced less FMS than 
younger persons. Levels of FMS decreased with increasing 
age above forty years. Stevenson et al. (196S) observed 
that infant and young children excreted more fat-mobilizing 
activity than did young male adults during an 18 or 24 hour 
fast. 
Beaton (1966) reported observations on the effect of 
age and sex on the excretion of FMS. Young male rats excrete 
a greater amount of FMS than do adult rats, the greatest 
excreted total activity per 100 gram body weight being at 
37 days of age (102 grams). The amount of FMS excreted did 
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not vary appreciably between 37 (102 grams) and 62 (197 gram~ 
days of age but was decreased between 62 (197 grams) and 78 
(297 grams) days. It is generally accepted that puberty in 
the rat is reached between 50 and 70 days. At the age of 
27 days, i.e., prepuberty, male rats fed a high fat diet 
excreted more FMS with a higher activity than did female 
rats. However, at 90 days of age (post-puberty), there was 
no apparent sex difference in the amount of total activity 
of FMS excreted per rat but when expressed per 100 gram body 
weight, females excrete more FMS than do males. 
Beaton et al. (1966a) investigated the lipolytic 
response of adipose tissue to rat FMS as affected by sex, 
age, and location of tissue. There was no sex difference in 
the response of perinephric and omentui!l adipose tissue. The 
response of adipose tissue of a young male rat was consider-
ably less than that of the adult male rat. 
Nobody knows the relationship, if any, bet'\veen FHS and 
the problem of human obesity. It is apparent, however, from 
even a brief perusal of jts biological effects, that this 
lipolytic factor probably arising in, or controlled by, the 
pituitary gland, may be part of a physiological homeostatic 
control of body mass (Gordon, 1970). The sensor or detector 
and the entire afferent portion of the mechanism have not 
been identified, either anatomically or physiologically, but 
its potential importance to the problem of weight control 
cannot be doubted (Gordon, 1970). 
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From observations on very obese patients, fasting and 
low carbohydrate diets appear to elicit a smaller output of 
FMS than in non-obese subjects (Chalmers, 1965). He consid-
ered the possibility that a primary defect of this mechanism 
plays a part in the development of obesity. Assuming that 
the urinary FMS is a reflection of the production of this 
substance in the body and its excretion by the kidneys, the 
higher mean urinary FMS levels in the group of non-obese as 
compared with the mean values in the obese subjects, toge-
ther with the observations of Chalmers et al. (1960) and 
Kekwick and Pawan (1968) that injected F.MS causes a mobili-
zation and reduction of the body fat content, suggest that 
a relative deficiency of FMS in obese persons may be associ-
ated with development of their obesity (Pawan, 1971). Pawan 
(1971) noted that it is of some interest that levels of Fr1S 
decrease in individuals with increasing age above forty 
years as there is evidence from actuarial studies of a posi-
tive correlation between incidence of obesity and age above 
forty years, particularly in women. The high FMS values in 
subjects with diffuse lipoatrophy observed by Pawan (1971), 
together with the elevated levels in physiological and path-
ological conditions of increased fat catabolism, support the 
hypothesis that FHS may be involved in the regulation of 
body fat stores (Pawan, 1971). 
Sustained use of FMS induces a fall in body weight in 
rats and in humans. Kekwick and Pawan (1968) placed six 
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obese patients on a 1500 calorie diet containing 120 grams 
of carbohydrate and gave injections every second day for 
varying periods of time, either with saline or with 25-100 
milligrams of FMS. After investigation for a total of 158 
patient-days, 80 with saline and 78 with FMS, 61 days of 
weight loss and 17 days without weight loss was reported 
during the 78 days of FMS injections in contrast to 21 days 
of weight loss and 59 days ~ithout weight loss during the 80 
days of saline injections. Kekwick and Pawan (1963) observ-
ed significant weight losses in mice kept in a metabolic 
chamber as a result of admnistering FMS, with ~oss of weight 
being produced in animals even when food intake remained 
constant upon presentation of an excess of food to the 
animals throughout the experiment. 
Repeated administration of FMS into animals for a 
period of up to three weeks causes weight loss; control 
animals receiving saline or non-fasting urine extract do not 
lose weight (Chalmers et al., 1960a). Loss of weight is not 
due to suppression of appetite; the treated animals remain 
in good conditions and their food intake does not differ 
significantly from that of the controls (Chalmers et al., 
1958, 1960a). Carcass analysis showed that loss of fat 
accounts for more than half the weight loss; the remainder, 
water and body protein, is unchanged (Chalmers, 1960a, 
1965). 
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FMS and Pituitary Hormones 
The ability to produce FMS in response to fasting, 
carbohydrate deprivation, and other conditions associated 
with increased catabolism of fat depends on the integrity 
of the adenohypophysis {or adjacent hypothalamus) . FMS does 
not appear during fasting of hypophysectomized animals orof 
human subjects with abnormal or absent pituitaries. There-
fore, an intact pituitary gland appears to be necessary for 
the production of FMS. 
While the urine of fasting, normal, and sham operated 
control animals contained fat-mobilizing activity, no such 
activity could be detected in the urine of hypo-physectomized 
goats fasting for up to five days {Kekwick et al., 1967}. 
Beaton et al., (1964a} demonstrated pituitary-dependence in 
rats. Urine extracts from fasting hypophysectomized rats 
contained no fat-mobilizing activity in vitro or in vivo. 
Chalmers et al. {1960a) reported seven studies in six 
patients with anterior pituitary deficiency. These included 
a patient whose pituitary had been removed for breast car-
cinoma three weeks before, three cases of chromophobe ade-
noma, a case of Sheehan's syndrome and a woman in whom the 
cause of hypopituitarism was unknown. All patients were 
receiving cortisone and thyroid in replacement dosage. When 
these patients were subjected to seve~e carbohydrate re-
striction or fasting for up to thirty-six hours, no fat-
mobilizing or ketogenic activity was detected in the urine 
by in vitro or in vivo techniques. 
Interestingly, FMS has been detected in the urine of 
hypophysectomized chickens (Nir et al., 1969). 
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The relationship of the pituitary gland and its hor-
mones to the fat-mobilizing substance of urine is unclear. 
It is not known, whether the pituitary is the origin of FMS 
in mammals or if it simply controls the formation and re-
lease of FMS else\-Jhere. However, comparisons of FMS '.vi th 
lipolytic substances of knovm pituitary origin reveal impor-
tant differences. Although preparations of FMS show weak 
melanophore-stimulating and in vitro corticotrophic activity 
(Chalmers, 1965) the evidence against the fat-mobilizing 
property being due to corticotrophin or MSH appears to be 
quite conclusive. Comparison of a preparation of FMS with 
corticotrophin A1 peptide gave widely differing potency 
ratios in three assay systems (Chalmers et al., 1960a). 
These were (FMS/corticotrophin) : (1) release of corticoids 
by rat adrenal in vitro-5/1000; (2) release of FFA by rat 
epididymal adipose tissue in vitro-25/1000; (3) increase in 
blood ketones in intact, unanesthetized mice-10-100/1. The 
corticotrophin peptide could be inactivated with hydrogen 
peroxide and partially reactivated with cysteine; FMS could 
be inactivated with hydrogen peroxide but could not be re-
activated with cysteine (Chalmers et al., 1960a). Both 
calcium and magnesium ions are required for the lipolytic 
effect of corticotrophin in vitro: FMS requires calcium 
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but not magnesium (Chalmers, 1964; Beaton et al., 1965, 
1966). Finally, both corticotrophin and melanocyte-stimu-
lating hormone are lipolytic in the rabbit as well as in the 
rat (Raben et al., 1961) but FMS is inactive in leporine 
adipose tissue (Chalmers, 1965). Species differences in the 
responsiveness of adipose tissue also differentiate FMS from 
the lipolytic peptides isolated from anterior pituitary 
glands by Rudman et al. (1961) and by Friesen et al. {1962), 
since these substances are active in rabbits and guinea pigs 
but not in rats or mice. Administration of commercial cor-
ticotrophin to normal subjects does not lead to the appear-
ance of fat-mobilizing activity in the urine and the urine 
of a totally adrenalectomized patient with a corticotrophic-
secreting pituitary tumor contained no FMS while on an un-
restricted diet but responded normally to carbohydrate 
deprivation with excretion of FMS (Chalmers, 1965). This 
observation supports the view that FMS is not corticotro-
phin-dependent and shows that functioning adrenal glands are 
not required for the production of activity in response to 
restriction of carbohydrate intake. 
The relationship between FMS and growth hormone remains 
an unresolved problem. Chalmers et al. (1960a) could find 
no fat-mobilizing activity in the urine of two hypophysecto-
mized patients after injection of human growth hormone (5mg 
intramuscularly) although plasma free fatty acids rose two 
to three fold in each case. The rise in plasma free fatty 
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acids produced by growth hormone is slower than that due to 
FMS and in vitro, growth hormone shows little or no lipoly-
tic activity (Vaughan and Steinberg, 1963), suggesting that 
the adipokinetic effect may belong not to growth hormone 
itself but to an agent produced in response to growth hor-
mone or possibly as a metabolite (Chalmers, 1965). Evidence 
that FMS is such an agent has not yet been obtained. Pre-
parations of FMS do not show growth-promoting activity and 
do not cross-react vvi th antisera to human growth hormone 
(Chalmers et al., 1960). Using an assay technique capable 
of detecting more than 1 microgram of growth hormone, Pro-
fessor F. C. Greenwood could find no evidence for growth 
hormone in FMS (1 to 100 ~g): It seems safe on these, and 
other grounds presented by Chalmers et al. (1960) and Chal-
mers (1965) to exclude growth hormone as the fat mobilizing 
factor in FMS (Pawan, 1971). 
In 1964, in the course of improving the method for the 
isolation of ACTH from ovine pituitaries, a new peptide was 
obtained which differed from all other then known pituitary 
hormones and had distinctive properties quite different from 
those of ACTH (Li, 1964; Birk and Li, 1964). Its biological 
behavior was tested after it had been characterized chemic-
ally. Upon isolation in pure form and establishment of its 
primary structure (Li, 1965), it was designated S-LPH (beta-
lipotropin) by Li because of its lipolytic activity. Li 
suggested the use of the term lipotropin "LPH" to define 
specific fat mobilizing pituitary hormones. 
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S-LPH has since 
been isolated from bovine (Lohmar and Li, 1967), porcine 
(Graf and Cseh, 1968; Gilardeau and Chretien, 1970) and 
human (Chretien, 1976; Cseh, 1968; and Scott and Lowry, 
1974) pituitaries. Li (1965) isolated S-LPH from sheep 
blood. 
The complete amino acid sequences of porcine (Graf, 
1971) and human (Li, 1976) S-lipoprotein have beenproposed. 
Comparison of the amino acid sequence of human B-lipotropin 
with that of the ovine and porcine S-LPH reveals the se-
quence of the COOH terminal 56 residues to be homologous, 
whereas the amino acid sequences at the NH 2 terminusexhibit 
considerable variability. 
Chretien and Li (1967) isolated in a homogeneous form 
another peptide with lipolytic activity calling it Y-LPH. 
Sequence of the 58 amino acids forming the Y-LPH molecule 
proved to be identical with the 1-58 N-terminal sequence of 
S-LPH. Both Y-LPH and S-LPH contain the entire sequence of 
S-MSH representing positions 41-58 of both the LPHs. Alpha-
MSH has the same amino acid sequence as the 1-13 residues 
of ACTH. ACTH, MSH, and LPH all contain a heptopeptide 
common core occurring at positions 4-10 in ACTH and a-MSH 
and at 46-52 in the B-MSH related peptides B-LPH and Y-LPH. 
All pituitary peptides which contain the heptapeptide core 
cause melanophore dispersion in frog skin, stinulate adrenal 
steroidogenesis and mobilize lipids from adipose tissue. It 
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has been shown by Sceh and Graf (1971) that the in vitro 
activity of the lipotropins, the most specific lipolytic 
pituitary peptides, has not surpassed that of ACTH which 
exerts other, e.g. steroidogenic potency too. In equimolar 
concentrations, ACTH was more potent than S-LPH, while Y-
LPH was ineffective in inducing lipolysis in rat adipose 
tissue. Human S-LPH, in contrast to human ACTH, is effec-
tive on human adipose tissue (Goth, 1971). 
S-LPH is the prohormone for morphine like peptides 
(met-enkephalin and endorphins). In 1975, Hughes reported 
the isolation of potent opiate-agonist activity of two pen-
tapeptides called met-enkephalin and leu-enkephalin, corre-
sponding to residues 61-65 in S-lipotropin. The C-terminal 
fragment of S-LPH (61-91) containing this 61-65 sequence of 
S-LPH was found to be 20 times more potent as an analgesic 
than the enkephalins (Bradbury, 1976). In 1976, [S-LPH-
(61-91)] was named S-endorphin (Li, 1976). Besides S-endor-
phin, Lazarus (1976) described the isolation and properties 
of a-endorphin [S-LPH-(61-76)] and a-endorphin [(S-LPH-(61-
77)]. 
Pelletier (1977) has shown that adrenocorticotrophic 
hormone (ACTH) and B-LPH are found in the same storage 
granules in corticotrophs and cells of the intermediate lobe 
of the pituitary. Mains (1977) using a mouse pituitary 
tumor cell line has shown that ACTH and B-LPH have a common 
protein precursor and that ACTH, B-LPH, and B-endorphin are 
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stored and then released together. Yalow and Berson (1971) 
believe 'big ACTH' synthesized by the pituitary gland to be 
the precursor molecule of both ACTH and LPH. 
Anselmino and Hoffman (1931) extracted from the ante-
rior lobe of the pituitary a substance inducing fat mobili-
zation and ketosis, and called it "Fettstoffwechselhormon". 
Etzrodt (1978) in studies on the pituitary "Fettstoffwechel-
hormon" isolated two peptides P-LF II C and P-LF II D from 
porcine pituitary glands which display a higher lipolytic 
activity than ACTH (Schleyer, Voight and Pfeiffer, 1976). 
Complete cross reaction was observed between porcine 
l- 39ACTH and P-LF II D. Etzrodt (1978) concluded that P-LF 
I h h . d . 1-39 I D as t e same 1mmuno eterm1nants as ACTH. 
Lelek (1963), Burns (1967), Trygstad (1967, 1968), and 
others have isolated fractions with lipolytic activity from 
the pituitary and blood. The characterization of their 
chemical and biological activities has not yet been done. 
Currently, it is not at all clear whether there exists 
a relationship between fat mobilizing substance (FMS) iso-
lated from the urine and many of these lipolytic substances 
isolated from the pituitary and blood. 
Mode of Lipolytic Action of FMS 
On the isolated rat fat pad, FMS produces an increased 
rate of release of free fatty acids into the incubation 
medium. This parameter has been utilized as the basis for 
the in vitro measurment of FMS lipolytic activity. Chalmers 
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et al. (1960a) demonstrated that a quantitative dose re-
sponse curve could be obtained. When the dose of fasting 
urine extract was varied the increase in liver fat was found 
to be linearly related to the log dose. FMS is active in 
vitro in releasing free fatty acids from rat adipose tissue 
at a concentration of less than 1 microgram per milliliter 
(Chalmers et al., 1960a), and some preparations of FMS are 
active at less than 0.1 ~g per ml (Chalmers, 1965). These 
authors showed that the rate of release is about half that 
produced by adrenaline and 40 times that produced by corti-
cotrophin on a weight for weight basis. 
In the intact mouse, subcutaneous injection caused a 
prompt fall in blood sugar, a rise in blood ketones as well 
as an increase in liver fat (Chalmers et al., 1960). The 
transient hypoglycemia reported by Chalmers et al. (1960a), 
lasting for about 2 to 4 hours, which diminishes on repeat-
ed injection presumably corresponds with the increased glu-
cose metabolism noted on isolated fat pads (Kekwick et al., 
1967). The effects onliver fat and blood ketones were max-
imal at six hours and subsided within twelve hours (Chal-
mers et al., 1960a). Blood lipids, including total lipids, 
phospholipids, cholesterol and free fatty acids also 
increased six hours after FMS injection (Chalmers, 1965). 
The increase in ketones and free fatty acids in the blood 
may last for over 48 hours after a single large injection 
(Kekwick et al., 1967). The effects on liver fat and on the 
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circulating levels of lipids and ketone bodies can be con-
sidered as the result of an increased rate of entry into 
the liver of free fatty acids released from adipose tissue. 
The following evidence support this view: (1) both rats 
and mice injected with FMS show a prompt rise in plasma free 
fatty acid concentration (Chalmers, 1965); (2) epididymal 
adipose tissue removed from rats previously injected with 
FMS release free fatty acids faster than tissue from saline-
injected animals (Chalmers, 1965); (3} addition of FMS to 
rat adipose tissue in vitro causes a marked increase in the 
rate of release of free fatty acids (Chalmers, 1965). 
Kekwick and Pawan (1963) studied the effects of admin-
istering FMS to mice kept in a metabolic chamber. Respira-
tory gas exchange was measured as well as carbon excretion 
in stools and urine. Daily injection caused only a small 
rise in oxygen consumption; carbon dioxide output did not 
increase and sometimes actually diminished, which was 
reflected in a drop in the 24 hour R.Q. (respiratory quo-
tient). Carbon balance, however, became markedly negative 
due to increased loss of carbon in the urine and, to a 
lesser extent, in the stools. Similar changes were 
found after daily injections of FMS for three weeks. The 
form in which the additional carbon is excreted is not 
completely clear but it is probably mainly in the form of 
ketone bodies representing the disposal of free fatty acids 
mobilized in excess of energy requirements. These results 
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appear to exclude the possibility that FMS, besides releasing 
free fatty acids into the circulation, may directly augment 
their oxidation in peripheral tissues (Chalmers, 1965). 
Moreover, FMS has been demonstrated to have no effect on the 
utilization of short-chain fatty acids by the isolated per-
fused rat heart (Chalmers, 1965). 
Upon extraction of FMS from the urine of fasting 
chickens, injection into chickens caused transient decrease 
in food intake and transient increase in plasma free fatty 
acids (Nir et al., 1969). These effects were accompanied 
by persisting decrease in plasma triglyceride, cholesterol 
and lipid phosphorus. Slight elevation of blood glucose 
occurred but it was not statistically significant. These 
results, so widely different from those obtained with mam-
mals, can only be possible if the process for the metabol-
ism of carbohydrate and fats differ widely in chickens and 
mammals. Some data indicate such a possibility. Protamine 
zinc insulin, for example, causes hyperphagia in mammals 
but, conversely, it causes anorexia in chickens (Lepkovsky 
et al., 1965). Moreover, the FMS from the urine of fasting 
chickens has.both anorexigenic and fat-mobilizing proper-
ties that cannot be separated into two fractions by the 
procedure of Beaton et al. (1964). 
Carbohydrate metabolism in rat adipose tissue is 
altered in a pattern similar to that of other lipolytic 
agents such as epinephrine and corticotrophin (Cahill et 
al., 1961). Cahill et al. (1961) studied the in vitro 
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effect of FMS on glucose metabolism and observed that FMS 
increases the incorporation of glucose carbon into glycer-
ide-glycerol in the same manner as does ACTH, epinephrine 
and growth hormone (Cahill et al., 1960; Lynn et al., 1960; 
and Leboeuf et al., 1961). These workers suggested that 
FMS primarily accelerates lipolysis and does not exert its 
action via inhibition of esterification. The rise in intra-
cellular fatty acids resulting from accelerated lipolysis 
induces the following: (1) increased glucose uptake; (2) 
increased glyceride-glycerol synthesis; (3) increased meta-
bolism of glucose via the Embden-Meyerhof (glycolytic) 
pathway; and (4) increased oxidation by the tricarboxylic 
pathway. Therefore, the action of FMS appears to be at the 
cellular level. 
It would appear that these in vitro observations sup-
port the in vivo situation. Louis et al. (1962, 1963) re-
ported that FMS has strong anti-insulin activity in the dog 
and suggested that the anti-insulin effect may be due to the 
increased fatty acid production. Randle et al. (1963) have 
shown that glucose uptake by muscle is inhibited by increas-
ed availability of free fatty acids for oxidation. 
The in vitro relationship between FMS and glucose was 
further studied by Beaton et al. (1966a) who observed that 
the in vitro lipolytic response of FMS can be abolished by 
addition of glucose to the incubation medium. It is possi-
ble that glucose aids triglyceride synthesis resulting in 
a net decrease in lipolysis. 
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In vivo, the hypoglycemic but not the ketonemic effect 
of FMS can be abolished in mice by intraperitoneal injection 
of glucose at the time of FMS injection (Chalmers). It has 
been shown that the hypoglycemic and fat-mobilizing proper-
ties of FMS are not mutually dependent and can be dissociat-
ed by ultrafiltration (Beaton et al., l966b). 
FMS produces no marked effect on protein metabolism. 
Nitrogenous equilibrium is undisturbed by injections of FMS 
as compared with periods on identical food intakes and 
saline injections (Kekwick et al., 1963). Repeated injec-
tions of FMS produce a significant diminution of carcass 
fat, but little alteration in carcass protein (Kekwick et 
al., 1963, 1967). 
Mechanism of Action 
In opposition to the hypothesis that all lipolytic 
agents act by releasing noradrenaline from tissue stores 
(Paoletti et al., 1961), observations of Chalmers and Gold-
iner (unpublished) do not support noradrenaline as an essen-
tial mediator of the lipolytic response to FMS: (l) Most 
adrenaline blocking agents when added, in vitro, depress the 
lipolytic response to FMS, namely; methalide, dibenzyline, 
tolazoline, and dihydroergotamine. (2) Some inhibitionofthe 
lipolytic effect of FMS by dichloroisoproterenol is seen but 
is far from complete even at higher concentration~ Athigher 
concentrations the effects of adrenaline and noradrenaline 
are completely blocked. (3) Rat adipose tissue depleted of 
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catecholamines by reserpine is fully responsive to FMS. 
Now, it is generally accepted that cyclic M1P plays 
a key role in hormonal regulation of lipid mobilization 
(Vaughan, 1961; Butcher et al., 1965; Robison et al., 197la 
and; Kwok, 1974). Investigation of FMS with labeled isolat-
ed fat cells indicates strongly that cyclic M1P plays an 
important role in 11polysis promoted by FMS (Kwok, 1973). 
Incubation of isolated fat cells for a brief period of time 
with increasing concentration of FMS resulted in increased 
cyclic ANP levels without a significant increase in lipoly-
sis. Longer incubation times demonstrated that lipolysis 
occurred and that it occurred after the maximal stimulation 
of adenylate cyclase. A synergistic effect of 1,2 dimethyl-
xanthine and FMS on lipolysis was demonstrated; while 
neither 0.25 ~~ theophylline nor 25 ugm of F~S strongly 
stimulated lipolysis, the combination of the two produced a 
striking response. Moreover, FMS is capable of increasing 
the intracellular cyclic k~P levels in intact isolated fat 
cells while inactive FMS (heat-treated FMS, proven to be 
inactive) did not increase cyclic &~P levels (Kwok, 1974). 
"That cyclic k~P levels are elevated before lipolysis 
is detected in cells treated with F~S (Kwok, 1974), is con-
sistent with the suggestion of previous investigators 
(Butcher and Sutherland, 1962) that cyclic ~{P is the cell-
ular mediator of hormone actions and may be related to the 
lipolytic cascade proposed by Steinberg (1971). After FMS 
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stimulation of the adenylate cyclase system, cyclic AMP 
activates protein kinase which in turn phosphorylates the 
hormone sensitive lipase, converting it from an inactive to 
a more active form. In this active form the enzyme controls 
the lipolysis of triglyceride to free fatty acids, FFA. 
Isolation and Purification of FMS 
FMS has been isolated from the urine by a four stage 
extraction procedure involving: benzoic acid precipitation, 
sodium carbonate solution or water extraction, alcoholic 
precipitation, and lyophilization (Beaton et al., 1964; Kek-
wick et al., 1967; Kwok, 1974). Chalmers et al., (1960a) 
reported that the use of oxycellulose increased the potency 
of the isolated product twenty to thirty times while Beaton 
et al. (1966b) reported that Millipore filtration and car-
boxymethylcellulose treatment are without any significant 
effect on the activity of the isolated product. Both Beaton 
et al. (1966b) and Kekwick and Pawan {1967) achieved some 
purification of the material by ultrafiltration through 
Visking dialysis membranes. The greater portion of the 
activ:ity \vas found in the ultrafiltrate. Kwok (1974) 
achieved some purification of the material by passage 
through a Diaflo ultrafiltration apparatus fitted with a PM-
10 membrane. Upon further purification of the active PM-10 
ultrafiltrate by ultrafiltration with a UM-2 Diaflo membrane, 
the activity was found to be associated with the UM-2 
residue (retentate). 
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When Beaton et al. (1966b) further fractionated the 
active ultrafiltrate, extracted from urine of fasting rats, 
through Sephadex G-25 chromatographic column with elution 
with distilled water, three active fractions were obtained. 
These activities did not appear to be necessarily associated 
with protein. The first active fraction coincided with the 
presence of carbohydrate although in small amount. The 
second active fraction coincided with the presence of carbo-
hydrate and some protein. The third active fraction coin-
cided with some protein. Consideration of these observa-
tions immediately raised the question whether rat FMS con-
tains three separate fat-mobilzing substances or whether 
there is but one compound attached to or absorbed by diffe-
rent carrier substances. The answer to this question has 
not yet been secured. In contrast, when the active UM-2 
residue (retentate) ultrafiltration product of Kwok (1974) 
was fractionated by passage through a Sephadex G-25 column 
with elution with distilled water, the activity was found 
to be associated only with the first ten 5 ml fractions. 
When Kekwick and Pawan (1967) passed their active 
ultrafiltrate extracted from the urine of fasting humans 
through a column of Sephadex G-50 and then through a column 
of Bio-Gel P-10, a reasonably homogeneous extract was 
obtained which migrated as a single band when subjected to 
electrophoresis on polyacrylamide gel and had one major com-
ponent peak in the ultracentrifuge with a small subsidiary 
peak. Kwok (1974) achieved further purification of his 
active UM-2 residue ultrafiltration product by column 
chromatography with a column of Sephadex G-50 and Bio-Gel 
P-10 set in tandem. When the active eluant peak fraction 
was subjected to electrophoresis on cellulose acetate and 
polyacrylamide gel, the preparation migrated as a single 
protein spot. 
Chemical Nature of FMS 
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Chalmers et al. (1960a) described the fat-mobilizing 
material they had obtained from the urine of fasting humans 
as a polypeptide with molecular weight less than 18,000. It 
is not ultrafiltrable and its behavior in dextran gel sus-
pensions suggests a molecular weight below 5,000 (Chalmers, 
1965). It contained about 8% nitrogen and after acid hydro-
lysis, it yielded the following amino acids: histidine, 
phenylalanine, leucine, serine, cystine, aspartic acid and 
a trace of alanine (Chalmers et al., 1960a). It gave a 
weak Molisch test for carbohydrate material. The biological 
activity was thermostable up to 80°C in 0.1 N sodium hydrox-
ide. It was destroyed by boiling for two minutes. Activity 
was completely destroyed by digestion with trypsin and 
chymotrypsin but some activity remained after peptic diges-
tion. 
Preliminary analysis of rat FMS extract by Stevenson 
et al. (1964) by paper chromatography after acid hydrolysis 
indicate that it is a polypeptide composed of histidine, 
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phenylalanine, leucine, serine, cystine, aspartic acid and 
alanine, with traces of 2 other amino acids. The extract 
obtained from fasted rats contained about 10% nitrogen and 
6% carbohydrate. Unpurified fat-mobilizing substance from 
rat urine was reported to contain several amino acids in 
addition to those listed by Chalmers et al.: The nitrogen 
contents of human and rat FMS are essentially the same 
(Beaton et al., 1964). Carbohydrate is also present in 
crude FMS obtained from rat urine (Beaton et al., 1964). 
FMS fractionation on Sephadex G-25 dextran gel by Beaton 
et al. (1966b) suggests a polypeptide molecular weight 
between 1,000 and 5,000. Kwok (1974) fractionated crude 
rat FMS into substances greater than 1,000 and less than 
10,000 in molecular weight by Diaflo ultrafiltration utiliz-
ing respectively, UM-2 and PM-10 Diaflo membranes; he 
showed that the active material, as isolated from rat urine, 
had a molecular weight between 1,000 and 10,000. Results 
from passage of U!1-2 retentate through Sephadex G-25 columns 
suggested that the active material may have a molecular 
weight between 5,000 and 10,000 daltons. 
Seifter et al. (1968), after studying the lipid mobil-
izing peptides from various sources, suggested that all 
lipid mobilizing peptides reported since 1956 are closely 
related chemically. Many questions concerning FMS cannot 
be answered until it can be isolated in pure form. 
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Statement of the Problem 
Production of FMS has been measured in vivo by using 
the ability of the urinary extracts to (1) raise blood ke-
tones, (2) raise free fatty acids levels in the blood of 
intact mice, and (3) diminish mouse carcass fat. Produc-
tion has been measured in vitro by the ability of FMS to 
release free fatty acids from the in vitro fat pad. During 
lipolysis both free fatty acids and glycerol are released. 
The fatty acids can be activated and reesterified. Glyce-
rol, however, is not metabolized to any significant extent. 
There exists the inherent danger of relying on only one 
criterion for measuring in vitro FMS lipolytic activity. 
To date, no in vitro bioassay utilizing glycerol has been 
employed in a quantitative comparison to free fatty acid 
release as an index of in vitro FMS lipolytic activity. It 
has become increasingly evident that differences in adipose 
tissue due to the number of adipose tissue cells and the 
size of these adipocytes can have an effect upon the meta-
bolic activity of the adipose tissue fat pad. Accordingly, 
attention need be directed to modification of assay proce-
dures to express the lipolytic activity of FMS as a function 
of cell size and number. 
The precise chemical nature of FMS remains elusive, and 
none of its physical characteristics have been reported. 
Progress has been hampered by the lack of highly purified 
preparations in sufficient quantity for basic studies. 
Application of the technique of iso-electric focusing to 
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this biologically active material may prove to be a power-
ful tool for future analytical and/or preparative separation 
of FMS. Physicochemical information can be obtained from 
isoelectric data to contribute towards characterization of 
FMS in terms of its physical properties. 
Obesity and age have been shown to affect the urinary 
excretion of FMS. Hence body weight probably has an effect 
on the quantity and quality of its excretion and should be 
studied in more detail. 
The purpose of this thesis is to obtain further 
information relevant to the characterization of this lipoly-
tic factor. Attention will be directed to the following 
parameters: (1) to improve the efficiency of purification 
of the active principle; (2) to investigate the influence 
of weight and age factors on its urinary excretion; and (3) 
to establish an assay system more specific for target cell-
FMS interaction than has been used previously, and based 
upon the release of glycerol and of fatty acid from fat 
cells of known size and lipid content. 
CHAPTER II 
MATERIALS AND METHODS 
General Experimental Procedures 
The first objective at the start of this work was to 
obtain a sufficient quantity of FMS for basic studies. 
Male albino rats of the Sprague-Dawley strain were placed 
on a high fat diet for a 7 day period. On the 7th day, the 
animals were placed in a cold room at 15°C and their urine 
was collected during a 24 hr fast. 
Crude FMS was extracted from the urine by a four stage 
process: (1) benzoic acid precipitation of FMS from freshly 
passed urine at pH 5.3; (2) extraction of FMS from the pre-
cipitate with distilled water; (3) alcoholic precipitation 
at pH 5.3; and (4) lyophilization of the precipitate after 
redissolving in distilled water. Crude, FMS was then bio-
assayed in vitro for lipolytic activity. 
The influence of weight, and hence age factors, on FMS 
bulk urinary excretion and activity were studied. Eleven 
groups of rats, 30 in each group and varying in mean group 
weight, were subjected to the above stated routine. The 
urine collected from the rats within a group was pooled, 
and the FMS extracted, weighed and bioassayed in vitro for 
lipolytic activity. 
Three different assay procedures were used to test the 
lipolytic activity of FMS. Being a relatively rapid and 
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accurate method, the lipolytic activity of FMS was assayed 
in vitro, at each stage of purification, by its ability to 
increase the release of free fatty acids (FFA) from epidi-
dymal fat pads of the rat in a medium of Krebs-Ringer phos-
phate buffer (pH 7.4) containing 4% bovine serum albumin. 
The quantitative release of FFA into the medium was deter-
mined by the method of Duncombe (1964) as modified and used 
by Kwok (1974). In this assay, chloroform-soluble copper 
soaps of the FFA are formed and the chloroform-soluble 
copper is converted to a colored complex by reaction with 
1,5 diphenylcarbohydrazide. 
To improve the sensitivity of this biological assay 
an experimental procedure was set up to assay the increased 
release of free fatty acids via direct FMS-fat cell inter-
action. Fat cell suspensions were used for this purpose 
and were prepared according to the method of Rodbell (1964). 
To remove the inherent problem of relying on only one 
criterion for measuring in vitro FMS lipolytic activity, a 
third assay, was established. In this case, increased gly-
cerol release from direct FMS-target cell interaction was 
quantitatively measured as an index of in vitro FMS lipoly-
tic activity. 
Glycerol release was determined by modification of the 
sensitive enzymatic method of Davidson and Karjala (1970). 
An Aminco-Bowman spectrophotofluorometer was used with 
excitation set at 350 nm and emission at 455 nm to measure 
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NADH 2 which is formed when glycerol is oxidized by glycerol 
dehydrogenase. 
Data obtained in FMS-target cell interaction assays 
were expressed in two v1ays. In the first approach, total 
lipid was extracted from the fat cells used in the assay 
system, by the biphasic system established by Felch et al. 
(1957) mixing chloroform, methanol and a known aliquot of 
cell suspension; the glycerol and/or free fatty acid re-
lease was expressed on a per unit cell lipid basis. 
The second mode of data expression provided an oppor-
tunity to study FMS lipolytic activity as a function of 
cell size and number. Increasing evidence shows that cell-
ularity of the adipose tissue can affect the metabolic 
activity of this tissue, and can provide an inaccurate 
amount of reported activity per target cell if expressed 
on a per unit wet weight of tissue basis. FFA release was 
expressed per 106 target cells, using rats weighing 130-
150 grams. 
Adipose tissue cellularity was determined on every cell 
suspension prepared for bioassay by use of the Coulter 
Electronic Counter, which gave cell number, as well as the 
means of obtaining the diameter and volume of the target 
cells used. 
The general approach and techniques of subjecting 
crude FMS to partial purification by ultrafiltration with 
PM-10 and UM-2 Diaflo membranes, and then further fraction-
ation by passage through Sephadex G-50 and Bio-Gel P-10 
chromatographic columns, were similar to those which have 
been used previously by Kwok (1974) in our laboratory but 
with some modifications. 
In the ultrafiltration studies the usefulness of the 
substitution of a DM-5 Diaflo membrane, for the UM-2 mem-
brane or of its incorporation into the existing purifica-
tion protocol along with the PM-10 and UM-2 membranes was 
investigated. 
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Column chromatography was applied to the active frac-
tions obtained from each of these modes of ultrafiltration. 
Both Sephadex G-50 and Bio-Gel P-10 columns in tandem and 
Bio-Gel P-10 columns alone were used in the further purifi-
cation of FMS. 
Highly purified FMS preparations were subjected to 
isoelectric focusing. The effluent was monitored with an 
LKB Absorptionmeter at 280 nm and fractions representing 
elution peaks were pooled, dialyzed, lyophilized, and bio-
assayed in vitro for lipolytic activity. 
The active variants of FHS were examined for homo-
geneity, amide gel electrophoresis and densitometry of 
the destained gel columns. 
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Chemicals 
Acrylamide, Eastman Organic Chemicals, ~o. 5521 
Albumin, Bovine, Fraction V Powder, Sigma Chemical Company, 
No. A4378 
Albumin, Dried Human Protein Standard, Dade (Div. of .~er-
ican Hospital Supply Corp., No. PR5-411 
Alcohol, 95%, Commercial Solvents Corporation 
Alcohol, absolute, Commercial Solvents Corporation 
Ammonium Persulfate, Mallinckrodt Chemical Works, AR, No. 
3460 
Ampholine Carrier Ampholytes, pH range 3-10, LKB Instru-
ments Inc., Rockville, Maryland 
Benzoic Acid, Aldrich Chemical Company, No. 10,947-9 
Bio-Gel P-10, 50-100 mesh, Bio-Rad Laboratories, No. 81102 
BIS (N,N'-Methylene-bisacrylamide), Eastman Organic Chemi-
cals, No. P 8383 
Bromphenol Blue (Water Soluble), Hartman-Leddon Company, 
No. 859 
Calcium Chloride, Anhydrous, Mallinckrodt Chemical Works, 
AR, No. 4132 
Casein, Nutritional Biochemicals Corporation 
Chloroform, Hallinckrodt Chemical Works, AR, No. 4440 
Collagenase, Type III, Fraction A, Sigma Chemical Company, 
No. C-0255 
Coomassie Brilliant Blue R-250, Colab Laboratories, Inc., 
No. ll-152B 
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copper Sulfate • 5H2 0, Mallinckrodt Chemical lvorks, AR, No. 
4844 
Crisco, Proctor and Gamble Company 
Cupric Nitrate·3H20, Fisher Scientific Company, No. 771342 
1,5 viphenylcarbohydrazide, Eastman Kodak Company, No. 618 
Fiber, Non-nutritive, Nutritional Biochemicals Corp. 
Glycerol, Reagent Grade, Fisher Scientific Co., No. G33 
Glycerol Dehydrogenase, Grade I, Sigma Chemical Co., No. 
50C-6860-l 
Glycine (Ammonia Free), Eastman Organic Chemicals, No. 445 
Hydrochloric Acid, J. T. Baker Chemical Co., No. 9535 
Isopropyl Alcohol, Mallinckrodt Chemical Works, AR, No. 
3032 
Kodak Photo-Flo 
Liver Powder, Nutritional Biochemicals Corporation 
Magnesium Sulfate·7H20, Mallinckrodt Chemical Works, AR, 
No. 6056 
Methanol, Anhydrous, Mallinckrodt Chemical Works, AR, 
No. 3004 
B-Nicotinamide-adenine dinucleotide, Grade III, Sigma 
Chemical Co., No. D 5755 
Palmitic Acid, Sigma Chemical Company, No. P-0500 
Perchloric Acid, Mallinckrodt Chemical Works, AR, No. 2766 
Phenol Reagent, Folin and Ciocalteu, Harleco Co. 
Phosphoric Acid, Hallinckrodt Chemical Works, AR, No. 2796 
Potassium Chloride, Granular, Mallinckrodt Chemical Works, 
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AR, No. 6858 
Potassium Ferricyanide, Sargent-Welch Scientific Co., AR, 
No. 14180 
Potassium Hydroxide, !1atheson, Coleman and Bell, No. CB 
1158 
Riboflavin, Eastman Organic Chemicals, No. 5181 
Salt l\iixture, Wesson Modified Osborne-Mendel, General Bio-
chemicals, No. 170900 
Sephadex G-50, Medium, Pharmacia Fine Chemicals Inc. 
Siliclad, Clay Adams Company 
Sodiurn Carbonate, Anhydrous, Mallinckrodt Chemical Works, 
AR, No. 7521 
Sodium Chloride, Mallinckrodt Chemical ~\forks, AR, No. 7 581 
Sodium Dodecyl Sulfate (SDS), Bio-Rad Laboratories, No. C-
161-0300 
Sodium Hydroxide, Pellets, Mallinckrodt Chemical Works, AR, 
No. 7708 
Sodium Phosphate Dibasic, Anhydrous, Mallinckrodt Chemical 
Works, AR, No. 7917 
Sodium Tartrate, Mallinckrodt Chemical Works, AR, No. 2386 
Sucrose, Nutritional Biochemicals Corporation 
Sulfuric Acid, Mallinckrodt Chemical Works, AR, No. 2876 
TEMED (N,N,N',N'-Tetramethylethylenediamine), Eastman 
Organic Chemicals, No. 8178 
Thymol, Aldrich Chemical Company, No. 11,209-7 
Toluene, Mallinckrodt Chemical Works, AR, No. 8608 
Trichloroacetic Acid I Hallinckrodt Chemical rvorks I AR, 
No. 2928 
Triethanolamine, Eastman Organic Chemicals, No. 1599 
'I'RIZlvlA-BASE, Sigma Chemical Company, No. T 1503 
TRIZHA-HCl, Sigma Chemical Company, No. T 3253 
Trypsin, Type III, from Bovine Pancreas, Sigma Chemical 
Company, No. T-8253 
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Trypsin Inhibitor, Type II-0, from Ovomucoid (Egg White), 
Sigma Chemical Company, No. T-9253 
Vitamin Diet Fortification ~1ixture, Nutritional Biochemi-
cals Corporation 
Urine Collection and Extraction of Crude FMS 
In all experiments, both for the collection of urinary 
FMS and for its bioassay in vitro, white male, albino rats 
of the Sprague-Dawley strain purchased from Locke-Erickson 
Laboratories, Maywood, Illinois were used. For the collec-
tion experiments, groups of 30 rats were immediately housed 
upon arrival into individual screen-bottomed cages at an 
environmental temperature of 25 + 1°C and fed laboratory 
chow ad libitum for the next 7 days. 
Following this period they were placed on a high fat 
diet for the following 7 days. The composition of the high 
fat diet is given in Table 1. The diet provided 84.7% of 
of the Calories as fat, 9.4% as protein and 5.9% as carbo-
hydrate with an average of 5.22 Calories per gram. The 
high fat diet was prepared every two days and was provided 
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TABLE 1 
CONSTITUENTS AND CALORIC CONTENT OF THE 
HIGH FAT DIET* 
Percent by Calories/ 
Constituent Weight Gram 
Casein 13 0.49 
Sucrose 8 0.31 
Crisco 50 4.42 
Non-Nutritive 
Fiber 24 
Salt Hixture 3 
Liver Powder 2 
Total 100 5.22 
* Plus 2% vitamins. 
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daily to the animals. Fresh drinking water was available 
ad libitum. 
On the seventh day of this regimen, the animals were 
weighed and transferred to individual stainless steel meta-
bolism cages, fitted with urine-feces separators, in the 
cold room at 15°C. The animals were then fasted for the 
next 24 hours, during which time urine was collected and 
pooled. The urine was collected in 125 ml Erlenmeyer 
flasks containing 5.0 mls of 10% thymol in isopropanol as 
a preservative. The preservative was not used however if 
the urine was to be processed immediately after its collec-
tion and this was generally the case. 
Following their 24 hour fast under cold stress, the 
rats were refed laboratory chow ad libitum at room tempera-
ture for the next 7 days before being placed back on the 
high fat diet and subsequently, the 24 hour fasting period 
and the cycle repeated. The experimental cycle was repeat-
ed for purposes of urine collection until the rats had 
reached weights over a group mean of 450 grams. 
Crude FMS was extracted from the urine according to 
the method of Beaton et al. (1964). The pH of the pooled 
24 hour urine collection from groups of 30 rats was pH 
adjusted to 5.3 with 1.0 N HCl. One volume of saturated 
benzoic acid solution in 100% ethanol was added for each 
10 volumes of urine with constant stirring. The slurry 
was mixed thoroughly for at least 15 minutes. Precipita-
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tion was allowed to proceed overnight at 4°C in a stopper-
ed container. The bulky precipitate which formed served 
to adsorb and coprecipitate F~S from the urine. The con-
tents were transferred to 100 ml Corning centrifuge tubes. 
0 0 The precipitate was centrifuged at 5,000 x g at 0 to 5 c, 
in an International Centrifuge, Model PR-2 {840a head), 
for 30 minutes. The supernatant was discarded. 
In order to remove the benzoic acid, the precipitate 
was washed in the large centrifuge tubes with cold 95% 
ethanol at pH 5.3. A glass rod was used to break up any 
lumps and to mix the contents thoroughly. The aqueous 
solution was then centrifuged at 5,000 x g at 0° to 5°C for 
30 minutes. The ethanolic washings were discarded on each 
occasion after centrifugation. The precipitatewaswashed 
twice. 
FMS was then eluted from the precipitate by adding 
100 ml of distilled water and mixing thoroughly over a 
period of about 15 minutes using a glass rod to break up 
any lumps. The aqueous solution was then centrifuged as 
before and the supernatant retained. 
Reprecipitation of FMS was carried out by adjusting 
the pE of the aqueous solution to pH 5.3 with 1.0 ~ HCl or 
1.0 N NaOH as required, and slowly adding 2 volumes of cold 
absolute alcohol while stirring constantly with a magnetic 
stirrer. 
The suspension was put in the cold room at 4°c for the 
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next 24 hours in a stoppered container for precipitation to 
be completed. The suspension was then transferred to 100 
ml Corning centrifuge tubes, and centrifuged at 5000 x g at 
0° to 5°C in the International Centrifuge, Model PR-2, for 
30 minutes. The supernatant was discarded. 
To the residue 50 ml of distilled water was added and 
the slurry mixed thoroughly and left for 15 minutes to dis-
solve the FMS. After centrifugation for 30 minutes at 0° 
0 to 5 C at 5000 x g, the supernatant was collected and lyo-
philized. The lyophilized product, crude Fr1S, was stored 
in the refrigerator in a tightly stoppered container. 
Free Fatty Acid Determination 
The lipolytic activity of FMS was assayed in vitro by 
incubation with epididymal fat pads from male rats in a 
medium of Krebs-Ringer phosphate buffer (pH 7.4) containing 
4% bovine serum albumin. The colorimetric method developed 
by Duncombe (1964), as modified by Kwok (1974), was used 
for the quantitative determination of free fatty acids (FFA) 
released into the incubation medium. In this assay, chloro-
form soluble copper soaps of the FFA are formed and the 
chloroform soluble copper is converted to a colored complex 
by treatment with 1,5 diphenylcarbohydrazide. 
Reagents 
1 M Triethanolamine: 14.9 gms of triethanolamine was dis-
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solved in deionized water and diluted to 100.0 ml with 
deionized water. 
6.45% Cu(No 3 ) 2 -3H2o: 6.45 gms of cupric nitrate trihydrate 
was dissolved in deionized water and diluted to 100.0 ml 
with deionized water. 
Copper reagent: A mixture of equal volumes of 1 M tri-
ethanolamine and 6.45% cupric nitrate trihydrate solution 
was prepared when needed. 
1,5 Diphenylcarbohydrazide Solution: 0.5 gm of 1,5 di-
phenylcarbohydrazide was dissolved in absolute methyl 
alcohol and diluted to 100.0 ml with absolute methyl al-
cohol. This solution was prepared just prior to use, as 
aging of this reagent results in increased blank values. 
Standard Fatty Acid Solutions: Six standard solutions of 
palmitic acid ranging from 20 ill1 to 120 uM in chloroform 
were prepared namely: 20 w~, 40 ~, 60 ~1, 80 uM, 100 u~, 
and 120 uM. 
Krebs-Ringer Phosphate Buffer (pH 7.4) Containing 4% Al-
bumin: Krebs-Ringer phosphate buffer containing the 
following components was prepared: NaCl, 128 mM; Mgso4 , 
1.4 ~~; CaC1 2 , 1.4 ~; KCl, 5.2 ~; and Na 2HP04 , 10 W-1. 
The phosphate buffer was made up fresh daily and the pH 
adjusted to 7.4 after addition of sufficient bovine 
serum albQmin to yield a 4% (w/v) solution. 
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Preparation of Standard Curve 
5.0 ml of each of the standard palmitic acid solutions 
were placed in glass-stoppered 17 x 135 mm (12 ml) Pyrex 
centrifuge tubes. In addition, 5.0 ml of chloroform 
was pipetted into an identical glass-stoppered centrifuge 
tube to serve as the blank. 2.5 ml of copper reagent was 
then added to each tube and the solutions were mixed 
thoroughly with a Vortex mixer set at top speed for 30 
seconds. 
The resulting two layers were allowed to separate 
and approximately 4 ml of the chloroform layer was removed 
with a 6", 18 gauge needle and syringe, and transferred to 
another 17 x 135 mm glass-stoppered Pyrex centrifuge tube. 
Extreme care was taken not to transfer any of the copper 
solution. About 2 ml of deionized water was added to the 
top of the chloroform layer in each of the tubes without 
any mixing of the two layers. The tubes were centrifuged 
in an IEC Clinical Centrifuge (809 head) set at speed #6 
for 10 minutes. 
The aqueous layer was completely removed along with 
a small amount of chloroform layer with a glass disposable 
pipet therefore, insuring that any small amount of the 
copper reagent remaining in the chloroform layer was remov-
ed. 
Aliquots of 1.0 ml of the chloroform solution of the 
soap were pipetted into 5.0 rnl volumetric flasks. 1.0 ml 
of the 1,5 diphenylcarbohydrazide solution was added to 
each flask, and the mixture was diluted to volume with 
chloroform. 
The absorbance of each solution at 540 nm was read 
in a Beckman DU Spectrophotometer exactly 5 minutes after 
the addition of the complexing agent. The data for this 
standard curve appear in Table 2. A linear relationship 
between the absorbance at 540 nm and the concentration of 
palmitic acid over the range of 4 uM to 24 W.1 is shown in 
Figure 1. 
Determination of Biological Activity of FMS Based on FFA 
Release from Epididymal Fat Pads 
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An epididymal fat pad weighing 250 mgs, removed from 
130-150 gm male rats was placed in a 25 ml Erlenmeyer flask 
containing 4 ml of Krebs-Ringer phosphate buffer containing 
4% albumin. After the addition of 100 ug of FMS (or test 
material) in 1.0 ml of the Krebs-Ringer phosphate buffer, 
the flask contents were incubated for 3 hours at 37°C in a 
Dubnoff Metabolic Shaker using air as the gas phase. 
At the end of the incubation, 1.0 ml of the incuba-
tion mixture was diluted with 1.0 ml of distilled water and 
extracted in a 18 x 150 mm glass-stoppered centrifuge tube 
with 5.0 ml of chloroform by mixing for 1 minute on a Vor-
tex mixer set at top speed. The mixture was centrifuged in 
an IEC Clinical Centrifuge (setting 6: 809 head) for 20 
minutes. The aqueous and chloroform layers were separated 
by a disc of precipitated protein. 3.0 ml of the chloro-
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TABLE 2 
Standard Curve Data for Determination of 
Free Fatty Acids 
Palmitic Acid No. of Absorbance* 
uM Determinations 540 nm 
4 12 0.061 + 0.021 
-
8 12 0.161 + 0.018 
-
12 12 0.258 + 0.021 
-
16 12 0.382 + 0.016 
-
20 12 0.493 + 0.021 
-
24 12 0.614 + 0.013 
-
* Mean + standard deviation 
-
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Figure 1. Standard Curve for the Determination of 
Free Fatty Acids. 
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5.2 
form solution were pipetted into a clean dry tube and ana-
lyzed for free fatty acids. The concentration of the FFA 
in the circulation medium was calculated from the regres-
sion line equation of absorbance versus concentration de-
termined by the method of least squares, namely F = 36.01A 
+ 2.18, where F represents the ru~ concentration of FFA and 
A, the absorbance value. The total FFA released to the 
medium as umoles was calculated by multiplying the value of 
F by the dilution factor. 
Preparation of Isolated Fat Cells 
Isolated fat cells were used in place of intact epidi-
dymal fat pads in an attempt to improve the existing assay 
used for free fatty acid release by the removal of the he-
terogeneous cell population that exists in fat pads (Butch-
er and Baird, 1968), and to increase the sensitivity of the 
fat cells to FMS through the increased sensitivity attribut-
ed to fat cells when assayed in their isolated form to li-
polytic agents (Fain et al., 1972). 
Fat cells were isolated according to the procedure of 
Rodbell (1964), as modified by Moskowitz and Fain (1970), 
and applied by Kwok (1974) in his investigation of FMS ele-
vation of cM11P levels with labeled adipocytes. 
White male albino rats weighing not more than 100 gms 
were purchased from Locke Erickson Laboratories in Maywood, 
Illinois. The rats were maintained on laboratory chow ad 
libitum until they weighed 130-150 gms, upon which, they 
were killed by decapitation. It has become increasingly 
evident that differences in adipose tissue mass, due to 
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the number of adipose cells in the tissue and their respec-
tive size, can have an effect on the metabolic activity of 
this tissue. Therefore, all preparations were made from 
rats weighing between 130-150 grams. The mean diameter of 
fat cells obtained from rats in this weight range is approx-
imately 45 urn, in contrast to a mean diameter of approxi-
mately 78 urn in rats weighing 400 to 450 grams. Small cells 
were used rather than the large cells since it has been 
demonstrated that large adipocytes from adult rats were less 
sensitive to glucagon stimulation of lipolysis than small 
cells from young animals (Manganiello and Vaughan, 1972; 
Livingston et al., 1974). 
Immediately after decapitation, the epididymal fat 
pads were removed quickly and rinsed in 0.9% NaCl. Poly-
ethylene centrifuge tubes and siliconized glass vessels 
were used during the preparation and incubation of the fat 
cells. Up to 10 grams of pooled rat epididymal fat pads 
were added to a siliconized 25 ml flask containing 10 ml of 
Krebs-Ringer phosphate buffer, pH 7.4, with 4% (w/v) bovine 
serum albumin. 10 mgs of collagenase and 4.0 mgs of cry-
stalline trypsin were added to each 25 ml siliconized Er-
lenmeyer flask. Cells were isolated by digestion with 
trypsin in addition to collagenase in order to diminish the 
effects of insulin and insulin-like substances on the re-
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sponse to lipolytic agents. No glucose was present during 
isolation or the incubation of the cells. When the in 
vitro relationship between FMS and glucose was studied by 
Beaton et al. (1966a), it was observed that the in vitro 
lipolytic response of FMS was abolished by addition of glu-
cose to the incubation medium. 
The mixture was incubated at 37°C for 1 hour in a 
Dubnoff Metabolic Shaker. The whole digest was then trans-
£erred to a polyethylene centrifuge tube containing 20 ml 
of Krebs-Ringer buffer warmed to 37°c. 
Fat cells were liberated from the tissue fragments by 
gentle stirring with a siliconized glass rod. Liberation 
of the fat cells was manifested by an increased turbidity 
of the medium. Fragments of tissue still remaining after 
this treatment were removed with forceps. 
The suspended cells were then centrifuged in poly-
ethylene centrifuge tubes for 1 minute at 400 x g. The fat 
cells floated to the surface and the stromal vascular cells 
sedimented. The stromal-vascular cells were removed by as-
piration. After gentle stirring of the cell suspension, 
fat droplets which formed from the breakage of some of the 
fat cells, floated more rapidly to the surface than the fat 
cells. These fat droplets were aspirated off from the sur-
face. The adipocytes were then washed by suspending them 
in 10 ml of warm Krebs-Ringer phosphate buffer and centri-
fuging for 1 minute at 400 x g; any remaining stromal vas-
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cular cells were aspirated off after centrifugation. Any 
remaining fat droplets were aspirated off the surface after 
gentle stirring. The washing procedure was repeated three 
times in order to insure complete removal of the stromal 
vascular cells. The adipocytes were finally suspended in 
20 to 25 ml of Krebs-Ringer phosphate buffer containing 
0.1 mg per ml of trypsin inhibitor. The cell suspension 
was swirled to ensure delivery of uniform suspension of 
cells immediately prior to use. 
Determination of the Biological Activity of FMS Based on 
FFA Release from Epididymal Fat Cells 
The lipolytic activity of FMS was measured in vitro 
on the basis of the increased release of free fatty acids 
from isolated fat cells in a medium of Krebs-Ringer phos-
phate buffer (pH 7.4) containing 4% bovine serum albumin. 
The colorimetric method developed by Duncombe (1964) as 
modified by Kwok (1974) was used, as it was applied to the 
in vitro bioassay using epididymal fat pads, for the quan-
titative determination of free fatty acids released into 
the medium. 
2.0 ml of fat cell suspension was placed in a 25 ml 
Erlenmeyer flask containing 2.0 ml of Krebs-Ringer phosphate 
buffer with 4% albumin. After the addition to the flask of 
100 ug of F~1S (or test material) contained in 1.0 ml of the 
Krebs-Ringer phosphate buffer, incubation was allowed to 
proceed for 3 hours at 37°C in a Dubnoff ~etabolic Shaker 
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using air as the gas phase. 
At the end of incubation, the incubation mixture was 
very carefully transferred to polyethylene centrifuge tubes. 
Fat cells were separated from the aqueous incubation mixture 
by rapid centrifugation for 1 minute in an IEC Clinical 
Centrifuge (speed setting 6: 809 head) for 20 minutes. The 
adipocyte layer was removed by aspiration. 
1.0 ml of the remaining incubation mixture was placed 
into a 17 x 135 mm glass-stoppered Corning centrifuge tube 
containing 1.0 ml of distilled water and extracted with 5.0 
ml of chloroform by mixing for 1 minute on a Vortex mixer 
set at top speed. The mixture was then centrifuged as before 
in the clinical centrifuge for 20 minutes. 3.0 ml of the 
chloroform solution were pipetted into a clean dry tube and 
analyzed for free fatty acids as described previously. The 
total FFA released to the medium as umoles was calculated by 
multiplying the value of F by the dilution factor and then 
dividing by 1000. 
The total FFA released to the medium was expressed as 
umoles of free fatty acids released by 100 ug of FMS (or test 
material) acting on rat epididymal adipose tissue fat cell 
0 
suspension equivalent to 1 gram of lipid for 3 hours at 37 C, 
and as umoles of free fatty acids released per 10 6 epididymal 
fat cells being acted upon by 100 ug of FMS (or test materi-
al) for 3 hours at 37°c. 
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Extraction of Total Lipid from Fat Cell Suspensions 
The lipid concentration of the adipose tissue cell 
suspension was measured by the method developed by Folch et 
al. (1957). 
Reagents 
Chloroform-Methanol Mixture: 2:1 (w/v). 
0.05% (w/v) Aqueous cacl2 : 50 mg of cac1 2 was dissolved in-
to distilled water and diluted to 100.0 ml with distilled 
water. 
Pure Solvent Upper Phase: Prepared by mixing at 3.0 ml ali-
quot of chloroform with 48.0 ml of methanol and 47.0 ml of 
0.05% CaC1 2 • 
Procedure 
8.0 ml of chloroform and 4.0 ml of methanol were plac-
ed in a separatory funnel. 2.0 ml of cell suspension in 
Krebs-Ringer phosphate buffer, pH 7.4, with 4% bovine albu-
min was added. The contents of the separatory funnel were 
shaken vigorously for approximately 30 minutes. Upon stand-
ing, a biphasic system was obtained, which contained no 
interfacial fluff. The volumes of the upper and lower phase 
were respectively, 40 and 60 per cent of the total volume 
of the system. The upper phase containing the non-lipid 
substances. The lower phase containing essentially all the 
lipids. 
This biphasic system was allowed to stand for 4 hours. 
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Afterwards, as much of the upper phase as possible was re-
moved by siphoning, and removal of its solutes was complet-
ed by rinsing the interphase three times with pure solvent 
upper phase mixture that contained 0.05% (w/v) Cacl 2 in 
place of water. In rinsing, 2.0 ml of pure solvent upper 
phase mixture was allowed to flow gently from a pipette 
onto the walls of the separatory funnel. The washing fluid 
collected on top of the lower phase without any mixing of 
the two phases. After the separatory funnel was rotated 
gently, the upper phase mixture was removed by siphoning. 
The lower phase was emptied from the separatory fun-
nel into a tared beaker. Following overnight evaporation 
the difference in weight represented the total lipid per 
2.0 ml cell suspension. 
Determination of Adipose Cell Size and Number 
In exploring the direct lipolytic effect of FMS on 
epididymal fat tissue consideration should be given to the 
cellularity of the chosen fat pads in terms of their cell 
size and number. It has become increasingly evident that 
differences in adipose tissue mass due to the number of 
adipose cells in the tissue and the size of these adipocytes 
can have an effect on the metabolic activity of this tissue. 
It has been demonstrated that large adipocytesexhibfr 
a marked resistance to the lipolytic action of glucagon v1hen 
compared to small cells (r1anganiello et al., 1972; Living-
ston et al., 1974). In vitro studies utilizing rat adi-
pose tissue or isolated fat cells have indicated that fat 
tissue from older animals is less sensitive to catechol-
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amines than fat tissue from younger animals. These observa-
tions connected with the knowledge that fat cell size in 
the rat increases throughout growth, has led to the con-
cept that fat cells may lose their sensitivity to the lipo-
lytic effects of catecholamines as they enlarge. Extending 
this concept to the obese individual who has fat cells of 
increased size projects the expectation of finding the same 
apparent metabolic deficit (Hartman et al., 1971). 
Hartman et al. (1971) demonstrated that when lipolysis 
is based on the amount of triglyceride in the incubation 
medium or on tissue weight, as is the usual custom, or on 
the cell surface area, lipolysis inversely relates to cell 
size. But when norepenephrine stimulated lipolysis was 
expressed per 10 6 cells lipolysis was independent of cell 
size. 
Experimental findings such as those noted above indi-
cate that the lipolytic action of FMS on adipose tissue may 
vary when using the tissue from rats differing in body 
weight and/or subjected to different experimental treatment 
if tissue cellularity is not taken into consideration. 
Therefore, a method based on cellularity may prevent mis-
leading information about the metabolic potential of FMS on 
its target tissue. 
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Various methods for determining adipose tissue cellu-
larity include the following: (1) microscopic examination 
of isolated fat cells in the unfixed state with the aid of 
an ocular micrometer, (2) DNA content which produces a 
nuclear, and hence cellular tally, and (3) electronic 
counting. The first method is tedious since it involves 
the measurment and counting of large numbers of cells which 
have the appearance of irregular polygons in various orien-
tations to the cut plane. The measurement of DNA in the 
intact tissue is an inexact estimate of adipose cellularity, 
since blood vessels, fibrous tissue, mast cells, etc., con-
tribute unknown amounts of DNA to the total. A determina-
tion of the DNA content of adipose cell suspensions may not 
be a valid estimate due to the cell breakage caused by 
collagenase treatment. As a result, the Coulter Electronic 
Counter, Model B (Coulter Electronics, Inc., Hialeah, Flo-
rida) was used to count and size the epididymal fat cells, 
because of its simplicity, accuracy and general applica-
bility. 
Coulter Counter Principle 
Particles or cells, suspended in an electrolyte can be 
sized and counted by passing them through an aperture with 
a specific path of current flow for a given length of time. 
As particles or cells pass through the aperture and 
displace an equal volume of electrolyte, the resistance in 
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the path of current changes. This results in corresponding 
current and voltage changes. The quantity (magnitude) of 
this change is directly proportional to the volumetric size 
of the particle or cell. The number of changes within a 
specific length of time is proportional to the number of 
particles or cells within the suspension. 
Preparation of Adipocytes 
Albino male rats of the Sprague Dawley strain (body 
weight range, 130-150 gms) were stunned by a sharp blow to 
the head and decapitated and the fat cells were isolated 
from epididymal fat pads after exposure to collagenase 
according to the method of Rodbell (1964). Cell prepara-
tions were made only from rats weighing between 130 gms and 
150 gms in the testing of FMS lipolytic activity on adipo-
cytes (FMS target cells). 
While the cell suspension was gently stirred, a 1.0 
ml aliquot was withdrawn into a siliconized glass pipette, 
added to isotonic saline, and the volume brought up to 10.0 
ml. A 1.0 ml aliquot of this stirred suspension was with-
drawn into a siliconized glass pipette, added to isotonic 
saline, and the volume brought up to 10.0 ml; obtaining an 
overall dilution of 1:100. This same double step dilution 
method was repeated when using Krebs-Ringer phosphate buffer 
as the diluent. The dilution was such that the cell concen-
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tration in the 0.5 ml sample to be monitored would fall be-
tween 1,000 and 80,000 cells. 
Agitation is often required to maintain uniformity in 
suspensions containing particles over 5 microns. Mainte-
nance of an uniform cell suspension during counting was 
achieved via continued gentle agitation during the process. 
The desired control settings were chosen and the count cycle 
initiated. 
Sixteen counts per threshold level (272 counts in 
total) were taken for each and every cell suspension prepar-
ation used for an in vitro bioassay of FMS. For one-half of 
these counts isotonic saline was used as diluting fluid 
(electrolyte) and for the other half, Krebs-Ringer phosphate 
buffer was used. 
On every cell suspension preparation the cell number 
per unit volume of cell suspension was calculated, and the 
average diameter of the cells in the cell suspension calcu-
lated. A frequency distirubtion of cell diameters was pro-
vided graphically for each cell suspension preparation. 
Glycerol Determination 
The biological activity of FMS was also measured, in 
vitro, by its ability to increase the release of glycerol 
from epididymal fat cell suspensions of the rat in a medium 
of Krebs-Ringer phosphate buffer (pH 7.4) containing 4% 
bovine ser~~ albumin. The amount of glycerol released into 
the medium was determined by the method of Davidson and 
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Karjala (1970), with modifications. The assay utilizes the 
fluorometric measurement of the reduced adenine dinucleotid~ 
NADH 2 , formed when glycerol is oxidized to dihydroxyacetone 
by glycerol dehydrogenase. 
Reagents 
1 N Perchloric Acid: 44.8 ml of the 70% (11.14 N), per-
chloric acid was dissolved into distilled water and diluted 
to 500.0 ml with distilled water. 
1.8 N KOH: 249.3 gms of 45% (w/v) KOH was mixed with dis-
tilled water and diluted to 1.0 liter with distilled water. 
Glycerol, Stock solution: 3.68 mg of glycerol was dissolved 
into distilled water and diluted to 100.0 ml with distilled 
water. Stock solution; 0.4 umole/ml. 
Glycerol Standards: Standard solutions of glycerol were 
prepared ranging from 0.04 to 0.40 umole per tube. 
0.1 M Glycine buffer, pH 9.5: 751 mgs of glycine, ammonia-
free, was dissolved into distilled water and diluted to 
100 ml with distilled water. The pH was adjusted to 9.5 
with 0.1 M NaOH. 
NAD: 3.0 mg of coenzyme NAD per ml of 0.1 ~glycine buffer, 
pH 9.5 was prepared just prior to incubation. 
Glycerol dehydrogenase: 0.15 Unit glycerol dehydrogenase 
per ml distilled water. 1 Unit oxidizes 1 umole of glycerol 
per minutes to dihydroxyacetone at pH 10.0 at 25°C. 
An Aminco-Bowman Spectrophotofluorometer and Ratio 
Photometer were used to measure the relative fluorescence 
intensity of NADH 2 with excitation set at 350 nm and an 
emission setting of 455 nm. The "Sensitivity" control on 
the ratio photometer was set at 3. The "Sensitivity Ver-
nier" control was set at its counterclockwise limit. 
Preparation of Standard Curve 
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Standard samples for the preparation of a standard 
curve were prepared by diluting various aliquots of the 
stock glycerol standard solution to 1.0 ml with distilled 
water in glass stoppered 17 x 135 mm Corning centrifuge 
tubes. Standard glycerol solutions were prepared ranging 
from 0.04 to 0.40 umole of glycerol per tube. One ml of 
distilled water was used as the enzyme-coenzyme blank. 
This 1.0 ml of distilled water, because it is carried 
through the deproteinization procedure along with the gly-
cerol standards, is referred to as deproteinized water in 
the table on "Blank and Sample Protocol for the In Vitro 
Bioassay of Fr-1:S". The glycerol standards were treated in 
the same manner as the unknown samples to compensate for any 
loss of substrate which may occur to the unknown samplesdur-
ing their deproteinization. When glycerol dehydrogenase 
(enzyme) and NAD are kept separate the fluorescence of each 
remains constant, but when the two are incubated together a 
small gradual increase in fluorescence occurs. Withaddition 
of 1.0 ml of distilled water (carried through the deprotein-
ization procedure) the resulting fluorescence is slightly 
greater. As a result an enzyme-coenzyme blank must be sub-
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tracted from all standard and unknown sample readings. A 
sample blank must also be subtracted from the corresponding 
unknown sample reading. 
Deproteinization was achieved by adding 2.0 ml of 1 N 
HC104 to each standard and enzyme-coenzyme blank. The con-
tents were mixed for 30seconds with a vortex mixer and then 
centrifuged for 15 minutes in an IEC Clinical Centrifuge 
(setting 6: 809 head). The standard and blank solutions 
were then very carefully transferred to a new set of glass 
stoppered 17 x 135 mm Corning centrifuge tubes. 1.0 ml of 
1.8 N KOH was added to each glycerol standard and theenzyme-
coenzyme blank to neutralize the standards and blank to pH 
7-8. The tubes were then cooled in ice for 10 minutes to 
ensure complete precipitation of potassium perchlorate and 
afterwards centrifuged for 10 minutes in an IEC Clinical 
Centrifuge. The resulting supernatant was decanted into a 
4.0 ml volumetric flask and brought up to 4.0 ml in volume 
with distilled water. Final volume was 4.0 ml for all the 
standards and enzyme-coenzyme blank. 
1.0 ml aliquots from each deproteinized standard and 
enzyme-coenzyme blank were placed in 17 x 135 mm graduated 
reaction tubes. 6.0 mg of NAD in 2.0 ml of 0.1 M glycine 
buffer, pH 9.5, was added to each reaction tube and to the 
enzyme-coenzyme blank. 0.15 Unit of glycerol dehydrogenase 
dissolved in 1.0 ml of distilled water was added to each 
tube and to the enzyme-coenzyme blank. After the above 
additions the standards and the enzyme-coenzyme blank were 
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incubated in a thermo-regulated v.rater bath set at room 
temperature, 25°C, using air as the gas phase for 90 
minutes. The assay was performed at room temperature to 
avoid the variable cooling of the reaction mixtures be-
tween incubation and reading. The completeness of the re-
action and the stability of NADH2 eliminate the necessity 
of exact timing. With the monochromator wavelength settings 
of excitation 350 nm and emission at 455 nm, the relative 
fluorescence intensity of each unknown sample was read 
quickly to avoid errors in measurement due to possible heat-
ing of the samples in the cell chamber. 
Thr fluorescence of each solution was read with exci-
tation at 350 nm and emission at 455 nm. The fluorescence 
of the enzyme-coenzyme blank was subtracted from each stan-
dard using the ratio photometer's "Blank Subtract" control. 
Figure 2 shows a linear relationship between relative fluo-
rescence intensity and the concentration of glycerol within 
the range of 0.01 to 0.10 umole of glycerol per tube. The 
data for this standard curve appear in Table 3. 
Determination of Biological Activity of FMS Based on Glycer-
ol Release from Epididymal Fat Cells 
1.0 ml of epididymal fat cell suspension was placed in 
a 25 ml Erlenmeyer flask containing 3.0 ml of Krebs-Ringer 
phosphate buffer with 4% albumin. After 100 ug of FMS (or 
test material) in 1.0 ml of Krebs-Ringer phosphate buffer 
was added to the flask, incubation was allowed to proceed 
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Figure 2. Standard Curve for Determination of Glycerol. 
TABLE 3 
Standard Curve Data for 
Determination of Glycerol 
Glycerol 
umole 
0.01 
0.02 
0.03 
0.04 
0.05 
0.06 
0.07 
0.08 
0.09 
0.10 
No. of 
Determinations 
20 
20 
20 
20 
20 
20 
20 
20 
20 
20 
Instrumental Parameters: 
Relative 
Fluorescence 
Intensity 
0.8 
1.6 
2.4 
3.2 
4.0 
4.8 
5.6 
6.4 
7.2 
8.1 
(1) A~inco Ratio Photometer - photomultiplier 
tube detector (PMT): 
R 456 (unpotted) PM tube and Cable PM tube 
(2) Slit No: 
Slit size (mm) 
3 4 7 
2 2 2 
(3) Excitation wavelength 
Emission wavelength 
Xenon Lamp Cat. No. 
(4) Sensitivity setting 3 
350 nm 
450 nm 
416-922 
Sensitivity vernier setting - Counterclockwise 
limit 
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for 3 hours at 37°C in a Dubnoff Metabolic Shaker using air 
as the gas phase. 
At the end of the incubation, a 1.0 ml aliquot was 
withdrawn from each of the incubation flasks and placed in 
glass-stoppered 17 x 135 mm Corning centrifuge tubes. The 
remaining contents from all the incubation flasks were pooled 
and 1.0 ml of the pooled incubation mixtures pipetted into a 
centrifuge tube to serve as the sample blank, which must be 
subtracted from each of the unknown sample readings. In 
addition, 1.0 ml of distilled water was pipetted into a 
Corning centrifuge tube to serve as the enzyme-coenzyme 
blank. (A minimum of four glycerol standards (two pair), 
one enzyme-coenzyme blank, and one sample blank were pre-
pared per assay.) 
The protocol for the in vitro bioassay of FMS based on 
glycerol release is given in Table 4. The fluorescence of 
the sru~ple blank was subtracted from the final reading of 
each unknown sample. The amount of glycerol present in the 
sample was calculated by reference to the standard curve of 
relative fluorescence intensity versus glycerol concentra-
tion. The total glycerol released into the medium as umoles 
was calculated by multiplying the concentration valueobtained 
from the standard curve by the dilution factor. Glycerol 
release was expressed umoles of glycerol released by 100 ug 
of FMS (or test material) acting on rat epididymal adipose 
tissue fat cell suspension equivalent to 1 gram of lipid for 
3 hours at 37°C. 
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TABLE 4 
Protocol for the 
In Vitro Bioassay of FMS 
Enzyme-Coenzyme Sample Sample Standard 
Blank Blank 
Deproteinized 1.0 ml 
Pooled sample 
Deproteinized 1.0 ml 
Sample 
Deproteinized 1.0 ml 
Standard 
Deproteinized 1.0 ml 
H20 
NAD 2.0 ml 2.0 ml 2.0 ml 
Enzyme 1.0 ml 1.0 ml 1.0 ml 
H 0 2 3.0 ml 
Final reaction mixture contained 6.0 mg of NAD and 0.15 U 
glycerol dehydrogenase in a total volume of 4.0 ml of 0.05 
M glycine buffer, pH 9.5 and incubated at 25°C for 90 
minutes. 
Purification of Crude FHS by Ultrafiltration and Column 
Chromatography 
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After assaying, on an individual basis, the crude FMS 
extracted from the urine of each group of rats, all the 
reamining crude FMS was pooled, dissolved in deionized water 
and the solution was lyophilized in a VirTis Uni-Trap Freeze 
Dryer (The VirTis Company, Inc., Gardiner, New York). The 
lyophilized pooled residue of crude FMS was then divided 
into three parts and each of the three parts was carried 
through an ultrafiltration procedure, separately, employing 
PM-10 and UM-2 Diaflo membranes. 
PM-10 Diaflo Membrane 
A 0. 05%(w/v) to 0.5% (w/v) aqueous solution of crude 
FMS was transferred to an Amicon Stirred Standard Ultrafil-
tration Cell, Model 52 (Amicon Corporation, Scientific 
Systems Division, Lexington, Massachusetts), fitted with a 
PM-10 Diaflo Membrane, which has a molecular weight cut-off 
of 10,000. A pressure of 30 psi was applied and the cell 
stirred at a relatively high rate. 
Ultrafiltration was allowed to proceed for about 1.5 
hours at an environmental temperature of 0° to 5°C. The 
ultrafiltrate and the residue were freeze-dried in the 
VirTis Uni-Trap Freeze Dryer, and bioassayed in vitro for 
lipolytic activity. 
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UM-2 Diaflo Membrane 
The biologically active fraction, the PM-10 filtrate, 
was then subjected to ultrafiltration, in a like manner, 
using a UM-2 Diaflo Membrane, with a cut-off at 1,000 in 
molecular weight. The ultrafiltrate and the residue were 
freeze-dried in the VirTis Uni-Trap Freeze Dryer and bio-
assayed in vitro for lipolytic activity. 
DM-5 Diaflo Membrane 
The biologically active fraction, the UM-2 residue, 
was further purified and the molecular weight of FMS fur-
ther approximated by subjecting this fraction to ultrafil-
tration using the newly patented DM-5 Diaflo Membrane, with 
a cut-off at 5,000 in molecular weight. The DM-Series is 
similar to the UM series of membranes in flow rate and re-
jection characteristics, and exhibits resistance to deter-
gents, salts and phosphates, which affect the UM structure. 
The UM-2 residue was subjected to ultrafiltration with the 
DM-5 membrane in the same manner as with the PM-10 and UM-2 
membranes and the ultrafiltrate and residue bioassayed as 
before. 
Bio-Gel P-10 
A 0.35% (w/v) aqueous solution of UM-2 residue, the 
biologically active fraction from the ultrafiltration with 
the UM-2 Membrane, was passed through a column (K 25/45, 
2.5 x 45 em, jacketed, Pharmacia Fine Chemicals Inc., 
Piscataway, N.J.) of Bio-Gel P-10 fitted with a Pharmacia 
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Flow Adaptor, A-25. 
h f h 1 . . d 0° T e temperature o t e co urnn was ma1nta1ne at -
5°C. Elution with distilled water was carried out at a 
rate of 1.8 rnl per minute and serial fractions 5 rnl in vol-
ume were collected with an Unifrac Fraction Collector 
(Savant Instruments Inc., Hicksville, New York}. The trans-
mission of the effluent at 280 nm was monitored with a LKB 
Uvicord ~Jsorptiometer and Recorder (LKB Instruments Inc., 
Rockville, Maryland}. The total volume of eluate was 500 rnl 
(100 tubes}. The collected fractions corresponding to in-
dividual elution peaks were pooled and lyophilized in the 
VirTis Freeze Dryer. Each peak ~·ms bioassayed in vitro for 
lipolytic activity. 
Sephadex G-50 and Bio-Gel P-10 
A 0.01% (w/v} aqueous solution of UM-2 residue, the 
biologically active fraction from the ultrafiltration with 
the UM-2 Membrane, was passed through a prepared column 
(K 25/45, 2.5 x 45 ern, jacketed, Pharrnacia Fine Chemicals 
Inc., Piscataway, N.J.} of Sephadex G-50 and then through a 
column (identical in type to the one just mentioned} of Bio-
Gel P-10, in tandem, as per Kwok (1974}. 
The column procedure used was that of Kwok (1974}. 
With the temperature of the column maintained at 0°-5°C 
elution with distilled water was carried out at a rate of 
2.5 rnl per minute and serial fractions 5 rnl in volume were 
collected with the Unifrac Fraction Collector. The trans-
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mission of the effluent was monitored with the Uvicord 
Absorptiometer and Recorder, set for monitoring at 280 nm. 
The total volume of the eluate was 500 ml (100 tubes) . The 
fractions corresponding to elution peaks were pooled and 
lyophilized in the VirTis Uni-Trap Freeze Dryer, followed 
by in vitro bioassay for lipolytic activity. A diagram of 
the scheme for the extraction of crude FMS from rat urine 
and purification of FMS via ultrafiltration and column chro-
matography is shown in Figure 3. 
Isoelectric Focusing 
Isoelectric focusing has become, in recent years, a 
powerful tool for the analytical or preparative separation 
of ampholytes, especially proteins, and for the characteri-
zation of the ampholyte by determining its isoelectric point 
(pi). The technique is characterized by a very high analy-
tical resolution and by simplicity of apparatus and method. 
Isoelectric point determinations of resolved proteins can 
now be accomplished conveniently and with great reproduci-
bility in a single experiment. Proteins with as small a 
difference as 0.02 pH unit separating their isoelectric 
points have been successfully resolved. 
Isoelectric focusing is obtained by imposing a direct 
current potential on a system of electrolytes. The whole 
interval between the electrodes is occupied by a series of 
ampholytes with pi ascending from anode to cathode, thus 
creating a pH gradient defined in each point by carrier 
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a1npholytes which are in their isoelectric states. 
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Each site 
along the gradient has its pH determined by the pH of the 
ampholyte at that point. When one adds a mixture of proteins 
with isoelectric points occurring within the pH range of the 
pH gradient, each protein molecule of the mixture migrates 
towards the pH value in the column where its net charge is 
zero. The pH gradient reaches a stable equilibrium if the 
system is stable for the duration of the experiment. Each 
protein of the mixture will be resolved at the point in the 
electrofocusing column where the pH is equal to the pi. Since 
this focusing, or resolution of proteins, is caused by an 
electric field, it has been named "Isoelectric Focusing". 
Ampholine Carrier Ampholytes 
Carrier ampholytes covering a pE range from pH 3 to 
pH 10, manufactured and marketed by LKB - Produkter AB, S-161 
25 Bromma Sweden, were obtained from LKB Instruments, Inc., 
Rockville, !1aryland, under the trade name of Ampholine Carrier 
Ampholytes, pH range 3-10. These synthetic ampholytes are 
aliphatic polyamino-polycarboxylic acids composed of a very 
large number of homologues and isomers of the same type of 
molecule which exhibit different, closely spaced pK and pi 
values. 
The ready-for-use mixture came in a 25 ml bottle at a 
concentration of 40% (w/v) water solution, and was stored in 
0 the dark at a low temperature (below 6 C) to prevent decompo-
sition, discolorization, and contamination by microorganisms. 
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The recommended concentration for electrofocusing 
proteins is 1 gm of Ampholine per 100 ml of solution. A 2% 
(w/v) ampholine solution was used when electrofocusing FMS 
in order to increase protein solubility. Ampholine chemi-
cals contribute to the solubility of proteins. 
Electrode Solutions 
Because the electrodes can communicate directly \.Yi th 
the separation compartment, the carrier ampholytes adjacent 
to the electrodes must be protected from anodic oxidation 
or cathodic reduction. This is accomplished by surrounding 
the anode with a dilute solution of phosphoric acid and the 
cathode with a dilute solution of sodium hydroxide. 
Electrolysis, during the electrofocusing experiment, 
drav;s the dilute acid and base solutions to their respective 
electrodes; the dilute phosphoric acid solution giving a net 
positive charge to any nearby carrier ampholytes, causing 
them to be repelled from the anode and hence protectedfrom 
electrolytic decomposition. At the cathode, the diluteNaOH 
solution, gives a negative charge to the nearby carrier 
ampholytes which are then repelled from the cathode. 
Phosphoric Acid Solution: Anode Electrode Solution 
The solution was composed of 0.2 ml phosphoric acid, 
14.0 ml distilled H20, and 12.0 gms of sucrose. Thedistil~ 
ed water was added to a 50 ml graduated cylinder containing 
12.0 gms of sucrose. The graduate cylinder was shaken manually 
until the sucrose was completely into solution. 0.2 ml of 
phosphoric acid was then added. The final solution volume 
equalled 23 ml. 
Sodium Hydroxide Solution: Cathode Electrode Solution 
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0.2 gm of NaOH pellets was dissolved into 20 ml of 
deionized H2 0 contained in a 30 ml Pyrex beaker. The entire 
volume of NaOH solution was pumped on to the isoelectric 
column. 
Density Gradient 
In order to prevent the remixing of separated zones due 
to thermal covection, and to stabilize the carrier ampholytes 
and protein sample zones, a density gradient of sucrose was a 
necessary prerequisite for the present technique. Any non-
ionic substance harmless to the sample and pH gradient can be 
used for preparing a density gradient. 
A linear density gradient was prepared by mixing a 
light solution containing distilled water, ampholytes, and 
sample (FMS), and a dense solution containing distilled water, 
ampholytes, and a "dense" solute (sucrose) with an LKB Gradi-
ent Mixer (LKB Instruments, Inc., Rockville, Haryland) design-
ed specifically for filling the electrofocusing column. With 
the Tygon tube and outlet tube clamped with pinch clamps the 
dense solution was added to the vessel that holds the spiral 
stirrer, followed by the addition of the light solution to 
the vessel that holds the tappered cone. The stirrer and cone 
were then placed into the vessels and the stirrer motor started 
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The pinch clamp between the light and dense solution vessels 
of the gradient mixer was loosened, quickly followed by the 
loosening of the clamp on the outlet tubing leading from the 
dense solution of the gradient mixer to the pump. A flow 
rate of 1 ml per minute was used. 
It took approximately 2 hours to fill the column. When 
the outlet tubing is first opened only liquid from the stirrer 
vessel flows through the outlet tubing. As the column is 
filled there is a continuous decrease in the density of the 
liquid until only the light solution passes through the outlet 
tubing, resulting 1n a gradually decreasing sucrose concentra-
tion from the bottom to the top of the isoelectric focusing 
column. 
Dense Solution: 2% Ampholine 
Three fourths of the total amount of carrier ampholytes 
(3.75 ml of 40% (w/v) ampholine solution), pH 3 to pH 10 was 
placed into a 100 ml graduated cylinder and diluted up to 42 
ml with distilled water. 28 grns of sucrose were dissolved in 
this solution by gentle warming and stirring, which gave a 
final total volume of 60 ml to this mixture. Of this mixture 
5.0 ml was discarded, the remaining 55 ml was added to the 
gradient mixer, placing it into the vessel that holds the 
spiral stirrer. 
Light Solution: 2% Ampholine 
One fourth of the total amount of carrier ampholytes 
pH 3 to pH 10 (1.25 rnl of 40% (w/v) ampholine solution) was 
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placed into a 100 ml graduated cylinder and diluted up to 60 
ml with distilled water. After this solution was thoroughly 
mixed, 5.0 ml was discarded, leaving a total of 55 ml of light 
solution which was added to the gradient mixer in the vessel 
that holds the tapered cone. 
Sample 
15 to 20 mgs of FMS were added to the light solution of 
the gradient mixer just prior to filling the column. 
Experimental Protocol 
The entire electrofocusing column (LKB 8100 ~mpholine 
Column, LKB Instruments, Inc., Rockville, Maryland) was ther-
mostated at 4°C by utilizing a cryostat (Tamson Thermostatic 
Bath (TM-9) and circulator (PBC-4, Neslab Instruments, Inc., 
Portsmouth, New Hampshire), which circulated coolant around 
both the inner and outer electrofocusing columns. The coolant 
consisted of equal volumes of distilled water and ethylene 
glycol. 
The central electrode valve was opened by depressing 
the spring located at the top of the glass column tube. This 
helical spring is in the setting device connected to the upper 
end of a Teflon rod that serves as a lever for the valve at 
its lower end. The central electrode is wound aroung this 
Teflon rod which lies within the central tube. The valve 
makes it possible to shut the central tube off from the sepa-
ration compartment when emptying. The helical spring keeps 
the valve normally closed. 
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The anode electrode solution was pumped into the cen-
tral electrode compartment, at top speed, via the upper nippl~ 
with an LKB 12000 Vario-Perpex pump (LKB Instruments, Inc., 
Rockville, Maryland). The central electrode served as the 
anode during the isoelectric focusing of FMS. The pump tubing 
was inserted all the way down to the bottom of the central 
electrode compartment. While filling, a few drops were allow-
ed to come out of the bottom of the column via the small piece 
of capillary tubing, which was then clamped shut again. 
In preparation to fill the separation compartment, the 
dense solution was added to the stirrer vessel on the LKB Gra-
dient Mixer, followed by the addition of the light solution 
to the cone vessel. After the stirring motor was turned on, 
the peristaltic pump was hooked up to the gradient mixer and 
set at 4 x 10, equalling a filling rate of 72 ml per hour. 
The polyethylene tubing was inserted about 2 inches into the 
lower nipple and against the side of the glass; thereby, pre-
venting the drops from falling and making the gradient uneven. 
FMS was added to the light solution and the clamps 
between the light and dense solution vessels loosened. Then, 
quickly, the clamp on the outlet tubing leading from the dense 
solution of the gradient mixer to the pump was loosened. 
After approximately 2 hours the solution mixed on the LKB Gra-
dient Mixer filled the electrofocusing compartment giving a 
linear density gradient. The pump and the gradient mixer were 
shut off. 
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The remaining space at the top of the electrofocusing 
column was filled with the cathode electrode solution which 
was pumped on top of the gradient at a pump speed setting of 
2.5 x 10 (a filling rate of 45 ml per hr). The column was 
filled until the cathode solution level reached the uper 
black line about 1 inch above the upper platinum electrode. 
The electrodes were then connected to an electrophore-
sis power supply (Gelman Instrument Co., Ann Arbor, Michigan), 
the anode electrode to plus via the plug at the central ele-
trode terminal located on the very top of the column, and the 
cathode electrode to minus via the plug at the upper electrode 
terminal located by its loop located at the top of the column. 
After the electrodes were in proper position they were 
tied to the supporting rack to make them immovable. The power 
supply was turned on and the voltage increased to a constant 
voltage of just under 500 volts. Upon completion of this last 
step, the electrofocusing of FMS has begun; a pH gradient is 
gradually being created and FMS is starting to migrate towards 
the point in the gradient corresponding to its isoelectric 
point. 
At first, the current on the milliampere meter read 10 
to 12 rna. This is because the water and the carrier ampho-
lytes inside of the column are all intermixed. When the cur-
rent (at a constant voltage of 500 volts) had decreased to a 
constant value of 2 rna most of the carrier ampholytes in the 
system had migrated at or near their isoelectric points. The 
FMS sample had also been focused at its isoelectric point to 
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a great extent; however, it took 48 hours to reach a steady 
final focusing. 
Final movement to the equilibrium state is slow, and 
the contribution of FMS to the conductance extremely low. As 
a result the change in conductivity time was so small after 
the current had decreased to the constant value of 2 rna, that 
no further current change registered in the time remaining 
for final completion of the electrofocusing run. In general, 
the focusing requires 10 hours or more extra time after the 
current has decreased to a constant value. An electrofocusing 
run normally takes from 24 to 72 hours at a voltage of 300 to 
500 volts, depending on the ampholine pH range used. Longer 
electrofocusing times are required for resolution of proteins 
in narrower pH ranges of ampholines. 
When the electrofocusing was completed, the central 
electrode valve was closed. Extreme care was taken to release 
the spring pressure very carefully, to prevent the gradient 
from being disturbed by bubbles which would result in incor-
rect pH values of the effluent fractions due to their contami-
nation with the anode electrode solution. The voltage was 
turned off and the jacks disconnected from the column. Then, 
at the fastest rate, the central electrode solution was pumped 
out of the column to prevent any leakage of the solution out 
of the central tube. 
After a thorough rinsing of the polyethylene tubing, 
the tubing was connected from the fraction collector to the 
electrofocusing column. The connection tubing was as short 
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as possible to prevent mixing. With 80 collection tubes in 
the fraction collector rack, the fraction collector was turned 
on. The counter on the fraction collector was set at 20 drops 
per fraction (1.8 ml per tube). 
The outlet clamp for the electrofocusing colQmn was 
then opened and the column was emptied by means of an LKB 
peristaltic pump set a 1.4 x 10 (a speed of approximately 22 
ml per hour) . It took about 6 hours to empty the entire 
column. 
The effluent was monitored with an LKB Absorptiometer, 
set for monitoring the effluent at 280 nm. 
The "Ambient Temperature" knob on the LKB Uvicord II 
Photometric Flow Analyzer was set at 1, for use at a coolant 
temperature 4 degrees centigrade. While the first fraction 
was being collected, the Uvicord was set at 2X the sensitivity 
scale. Once this was accomplished the "T%" was dropped back 
from 100% T to about 40-45% T so the entire column could be 
monitored. If this is not done the collection won't be able 
to be monitored. A low reading of 40 to 45% T will be record-
ed for the first couple of fractions due to significantly high 
values of absorption in that part of the gradient. However, 
after these first couple of fractions the absorption gets much 
lower, and T% much higher. If the recorder bar had been 
originally set at 100% T the low absorption fractions would 
cause the recorder bar to go "Off" scale, resulting in an un-
monitored collection. 
I'ieasurement of pH 85 
Measurement of the pH of the collected fractions pro-
vides a picture of the pH gradient, making it possible to 
determine the isoelectric point of each component of the sam-
ple with the accuracy obtainable with the pH meter being used. 
The pi is dependent on the temperature, but there is 
no reliable factor which allows conversion of a pi measured 
at one temperature to the pi corresponding to another tempera-
ture. As a result the pH of the fractions from electrofocus-
ing were measured on a Beckman Phasar-1 pH Meter at the same 
temperature as used during electrofocusing. 
Data Analysis: Measurement of the Result 
The LKB Uvicord II Photometric Flow Analyzer records 
the UV absorption curve on paper. The volume of the eluted 
liquid, or the corresponding length of the column in ern's, 
is plotted along the x-axis. The pH gradient is also plotted 
on the same diagram. The y-axis is divided into pH units, 
starting with the lowest and ending with the highest values 
of the pH gradient used. 
Removal of Carrier Arnpholytes from F.HS Fractions 
The FMS was separated from the sucrose and carrier 
arnpholytes by means of dialysis using #3 Spectrapor Membranes 
(Spectrum Medical Industries Inc., Los Angeles, California). 
Since some of the Arnpholine carrier ampholyte molecules have 
a molecular weight of more than 1000, they pass through the 
dialysis membrane rather slowly. Therefore, dialysis required 
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48 hours before all the carrier ampholytes had been removed. 
The dialyzing sacs were closed by using Spectrapor 
Closures. Spectrapor closures were used instead of tying a 
knot in the wet tubing since knot tying can distort pores in 
~et tubing. String tying was not used because the string can 
cut tubing. 
Protein Determinations 
The protein concentrations of the fractions of FMS 
obtained from electrofocusing were measured using the method 
of Lowry et al. (1951). This very sensitive method is based 
on the fact that a deep blue color is formed when protein in 
alkaline copper solution is treated with the phenol reagent 
of Folin and Ciocalteu (1927). 
Two distinct steps are involved in the reaction. 
First, the protein reacts with copper in alkaline solution, 
and second, a reduction of phosphomolybdic and phosphotung-
stic acid by the copper-treated protein occurs. 
Preparation of Standard Curve 
Reagents 
1% Sodium Dodecyl Sulfate (SDS): 1 gram of CH3 (cH2 ) 11oso3Na 
was dissolved in distilled water to a volume of 100 ml. 
2% Sodium Carbonate in 0.1 N Sodium Hydroxide: 0.1 N NaOH was 
prepared by adding 0.4 grams of NaOH to enough distilled water 
to make 100 ml of solution. 2 grams of Na 2co3 were mixed with 
a quantity of the 0.1 N NaOH solution sufficient to give 100 
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ml of solution. This reagent was prepared fresh just before 
use. 
2% Sodium Tartrate: 2 grams of Na 2c 4H4o 6 · 2 H2o v1ere dissolved 
in distilled water and the solution diluted to 100 mls with 
distilled water. 
1% Copper Sulfate: 1 gram of cuso4 ·5 H20 was dissolved in 
distilled water and the solution was diluted to 100 mls with 
distilled water. 
Phenol Reagent of Folin and Ciocalteu, lN: A commercially 
prepared solution of the phenol reagent, 2 N, was purchased 
from Harleco, Philadelphia, Penn. A working solution was pre-
pared from this, each day of use, by diluting a small volume 
of the stock solution with an equal volume of water to give a 
1 ~phenol reagent. 
Standard Protein Solution: Crystallized human albumin, pur-
chased from Dade Division of American Hospital Supply Corpora-
tion, Miami, Fla., was used for the preparation of a standard 
protein solution. 1'7hen reconstituted with 3. 0 ml of distilled 
water, the standard contains 80 mg of protein per ml. 
Working Standard Protein Solution: A working standard protein 
solution of 80 ug/ml was prepared just before use by diluting 
0.1 ml of the protein standard solution to 100.0 ml with dis-
tilled water. 
Procedure 
Standards for the preparation of the standard curve 
were prepared by diluting various amounts of the working 
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standard solution to 1.0 ml with distilled water. One ml of 
distilled water was used as blank. 
To 100 ml of the 2% sodium carbonate in 0.1 N sodium 
hydroxide, 1.0 ml of 2% sodium tartrate and 1.0 ml of 1% 
copper sulfate were added, and thoroughly mixed. Five ml of 
this mixed reagent was then added to each blank and standard. 
After mixing, they were left to stand at room temperature for 
10 minutes. 
One-half ml of the 1 ~ phenol reagent was added to each 
tube and mixed i~mediately. After 30 minutes or longer the 
absorbance was measured at 700 nm in a Beckman DB Spectropho-
tometer. The data for this standard curve appear in Table 5. 
A linear relationship between the absorbance at 700 nm and the 
concentration of protein within the range of 16 ug to 80 ug is 
shown in Figure 4. 
Determination of FMS Protein Concentration 
1 mg from each of the fractions of FMS obtained from 
electrofocusing was added to. distilled water, and the volume 
then adjusted to 10.0 ml. 
Various aliquots of the same FMS test solutions were 
diluted to a total volume of 1.0 ml with distilled water and 
analyzed for protein content. The amount of protein p~esent 
was calculated by reference to the standard curve. 
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TABLE 5 
Standard Curve Data for 
Determination of Protein Concentration 
Micrograms No. of Absorbance* 
of Protein Determinations 700 nm 
16 5 0.014 + 0.001 
32 5 0.061 + 0.002 
48 5 0.114 + 0.008 
64 5 0.160 + 0.005 
80 5 0.216 + 0.002 
* Jl.1ean + Standard Deviation 
0.25 
E 
c 
0 
0 
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IU 
() 
z 
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Figure 4. Standard Curve for Determination of Protein 
Concentration. 
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Polyacrylamide Gel Electrophoresis of FMS 91 
The fractions of FMS obtained from electrofocusing were 
subjected to polyacrylamide gel electrophoresis utilizing a 
Hoefer Disc Electrophoresis Unit (Hoefer Scientific Instru-
ments Co., San Francisco, California). Anionic polyacryl-
amide gels were used for the electrophoresis. 
Reagents 
Stock Solutions 
Stock solutions were prepared as outlined in Table 6 
using deionized water and were filtered and stored in brown 
glass bottles or bottles wrapped in foil in the refrigera-
tor. Most of these stock solutions had a shelf life of up 
to three months. 
Working Solutions 
Working solutions were prepared as outlined in Table 7 
fresh from the stock solutions on the day they were to be 
used. 
Fixative, Fixative-Stain, and Destaining Solution 
The fixative solution and the solution for washing and 
destaining the polyacrylamide gels were prepared in advance 
and stored at room temperature, Table 8. The Coomassie 
Brilliant Blue R-250 was prepared as an aqueous stock solu-
tion which was stirred and filtered prior to use. This 
stock solution was diluted 1:20 with 10% trichloroacetic 
acid (TCA) just prior to staining the gels. The fixative 
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TABLE 6 
Anionic Gel Stock Solutions 
Separation Gel 
(Small-pore gel) 
(A)* 
1 N HCl approx. 48 ml 
Trizma-Base 36.3 gm 
water to 
(pH 8. 9) * 
(C) 
Acrylamide 
BIS 
Potassium Ferri-
cyanide 
water to 
(E) 
0.46 ml 
100.0 ml 
30.0 gm 
0.8 gm 
0.015 gm 
100.0 ml 
Ammonium Persulfate 0.14 gm 
water to 100.0 ml 
Sample and Stacking Gels 
(Large-pore gels) 
(B) 
1 N HCl approx. 48 ml 
Trizma-Base 5.98 gm 
TEMED 0.46 ml 
water to 100.0 ml 
(pH 6. 7) * 
(D) 
Acrylamide 
BIS 
water to 
(F) 
Riboflavin 
10.0 gm 
2.5 gm 
100.0 ml 
0.004gm 
water to 100.0 ml 
*pH adjusted by titrating with 1 N HCl before dilution to 
100 mls. 
TEHED- N,N,N',N'-Tetramethylethylenediamine 
BIS - N,N'-Methylene-bisacrylamide 
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TABLE 7 
Anionic Gel Working Solutions 
Separating Gel Sample and Stacking Gel Buffer 
(Small pore gel) (Large-pore gel) Solution 
1 Part A 1 Part B TRIZHA-BASE 6. 0 gm 
2 Parts c 2 Parts c Glycine 28.8 gm 
4 Parts E 1 Part F Water to 1 liter 
1 Part Water 4 Parts Water 
pH 8.9 (8.8-9.0) pH 6.7 (6.6-6.8) pH 8.3 
TABLE 8 
Fixative, Staining and Destaining Solutions 
TCA 10% 
Stock Solution: 
Fixative Solution 
Fixative-Stain Solutions 
Coomassie Brilliant Blue 
Coornassie Brilliant Blue 1 grn 
Water to 100 ml 
Working Solution: 
12.5-20.0% TCA* 
Stock Solution 
TCA 10% 
20 rnl 
1 rnl 
Destaining Solution 
* A further increase in sensitivity can be 
achieved by the use of a 20% TCA dye solvent. 
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stain solution was made up fresh from the stock solution 
before use. 
Procedure 
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Twelve Pyrex glass columns (10 em long and having an 
inner diameter of 0.5 em and an outer diameter of 0.7 em) 
were acid cleaned and coated with a wetting agent (1 part 
Kodak Photo-Flo to 200 parts water) . Base caps (vacutainer 
tops) were placed at one end of the gel columns which were 
then placed into a loading rack in which front-to-hack 
vertical alignment of the gels could be assured. 
Stock solutions A, C, and E were removed from the 
refrigerator and 4 ml of solution A, 16 ml of solution E, 
8 ml of solution C, and 4 ml of deionized water were placed 
in separate flasks and allowed to warm up to room tempera-
ture. Approximately 20 mls of separation gel solution was 
the volume required to run twelve 10 em long gels. The 
four components were then added to a single flask and 
swirled gently to prevent air bubble formation and to pro-
vide thorough mixing. This was the separation gel solution. 
Using a 1 ml tuberculin syringe, to which 5 em of Tygon 
tubing was attached, exactly 1.6 ml of the separating gel 
solution was dispensed (without bubble formation) into each 
of the 12 vertical gel columns. 
An Oxford pipette was then used to carefully layer 100 
ul (2-3 rom) of water on top of the gel solution. If the gel 
columns are not coated with a wetting agent prior to their 
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use, a bolus of water will form which \vill drop into the gel 
solution and dilute it. However, if the gel columns are 
coated, water will layer evenly on top of the unpolymerized 
gel solutions. The purpose of the water layering of gel 
solutions is that it prevents a gel-air meniscus and pro-
duces a flat gel surface which is essential for obtaining 
good protein band formation. It also prevents oxygen, which 
retards gel formation, from diffusing into the gels. 
The separation gels were left undisturbed for one half 
hour during which time complete chemical polymerization 
occurred as was evident by the visibility of a distinct 
refractile line between the gel and water interface. 
The gel columns were then removed from the loading 
rack and the water layer was removed by giving the column a 
quick flick of the wrist. The lip of the gel column was 
then touched to a piece of absorbent paper to remove the 
last traces of water. 
Two milliliters of solution B, 4 ml of solution D, 2 ml 
of solution F, and 8 ml of water were pipetted into another 
set of small flasks. These solutions were warmed to room 
temperature and gently mixed in a flask that was completely 
wrapped in foil to protect this gel solution from premature 
photopolymerization. This solution was to serve as the 
photopolymerizing stacking and sample gel. A 1 ml syringe 
with Tygon tubing adapter was then used to add 0.3 ml of 
this solution to each gel column. This served as the 
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stacking gel. Once again, 100 ul of water was layered over 
this gel solution as previously described. The entire load-
ing rack was positioned approximately 30 ern from a fluore-
scent light source. Fifteen minutes were allowed for photo-
polymerization to begin as evidenced by the appearance of 
opalescence in the stacking gel. When photopolyrnerization 
had begun, the light source was moved to within 5 ern of the 
columns and another 15 minutes were allotted to insure total 
photopolyrnerization. The water layer was then removed as 
previously described. 
Exactly 1.0 rng of the FMS preparation to be tested was 
dissolved in 1.0 rnl of the stacking and sample gel solution 
and 0.250 rnl of the solution was added on top of the stack-
ing gel and layered with 100 ul of water. The sample gel 
was allowed to photopolyrnerize for 30 minutes while posi-
tioned 5 ern from the fluorescent light. 
Bromphenol blue (0.1 to 0.2 rnl of a 0.001% solution), 
serving as a tracking dye, was incorporated into the sample 
gel solution prior to its addition to the gel column. This 
dye migrates faster than the fastest sample ion species. 
The gel columns were then removed from the loading rack 
and inserted into the holes of the upper bath stoppers 
(sample gel uppermost). After all the gel columns were in-
serted in this manner, buffer was added on top of the sample 
gels, making certain that no air bubbles were entrapped in 
the remaining space of the upper gel column. The entire 
upper bath assembly containing the gel columns was then 
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lifted out and sufficient buffer solution was added to the 
separation gels such that a hanging drop of buffer solution 
remained at the bottom of all the gel columns. It is 
essential that no air bubbles are entrapped in the gel 
columns. 
The lower bath (containing the anode) of the Hoefer 
Electrophoresis Apparatus was then filled with 1000 ml of 
buffer solution. The upper bath assembly was then carefully 
placed into position making certain that no air bubbles had 
formed at either end of the gel columns. Air bubbles result 
in uneven band formation because they prevent a uniform 
current flow through the gels. The upper buffer reservoir 
was then filled with 500 ml of buffer solution. 
The lid was then placed on the upper bath. The power 
supply was connected. A current of 2.5 rna per gel column 
provided for good resoltuon of protein bands. Electropho-
resis was carried out until the now discrete front of track-
ing dye band had migrated to within ~ inch of the separation 
gel end. This required approximately 1 hour and 30 minutes 
at 2.5 rna per gel column. 
At the completion of electrophoresis, the power supply 
was turned off and the electrode jacks were disconnected. 
The gel columns were removed from the upper reservoir and 
were placed in a wash tray containing ice-cold water. The 
gels remained immersed in the ice-cold water for 5 minutes 
which was sufficient time for maximal gel contraction. A 
ten milliliter syringe fitted with an 18 gauge needle was 
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filled with ice-cold water. The gel columns were kept 
submerged while the tip of this needle (beveled edge 
towards the gel to avoid scratching the gel) was inserted 
between the glass column and the gel. The needle was in-
serted slightly beyond the sample gel of the gel column. 
Keeping the gel columns submerged and the needle flat 
against the glass surface, the entire gel column was ro-
tated with one hand while the position of the needle was 
maintained. This freed the entire circumference of the 
sample gel from the glass column. Ice-cold water was con-
tinuously injected around the gel surface as the gel column 
was rotated. The water pressure freed the stacking and 
separating gels and in a few moments the intact gel was 
expelled from the separating gel end of the glass column. 
The gels were quickly placed in a 10% solution of TCA 
for a minimum of one hour to insure that the protein frac-
tions were fixed uniformly. The gels were then stained by 
immersion into 20 ml of the Coomassie Brilliant Blue working 
solution for another hour. Minute protein bands were well 
detailed in 20% TCA-Coomassie Brilliant Blue stain solutions. 
Destaining was done by three consecutive immersions of the 
gels into 10% TCA solution, each immersion lasting about an 
hour. The gels were then immersed into 10% TCA solution 
and the TCA solution was changed every day for approximately 
3 days. When the section of a gel, containing no separated 
fraction was completely clear of stain, the gel was trans-
ferred to a solution comprised of equal parts of glycerol 
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and deionized water. This allows for the storing of gels 
without shrinkage. 
Densitometry of Polyacrylamide Gels 
Densitometry of the gels was performed with a Densicord 
Model 542 Densitometer (Photovolt Corporation, New York, 
N.Y.). The proper response setting was chosen and the 
stained separation gels were scanned over their entire 
length by the Densicord. The percentages of the various 
fractions from the densitometer trace were determined by 
establishing the area under the curve at all points. 
Photography of Polyacrylamide Gels 
A Polaroid camera with a close-up lens was a convenient 
method of photographing stained polyacrylamide gels. 
CHAPTER III 
Results 
Effect of Body Weight and Age of the Rat on the Bulk Urin-
ary Excretion, Total and Specific Activity of FMS 
Eleven groups of 30 male albino rats varying in mean 
group weight from 152-416 grams were placed on a high fat 
diet with water ad libitum for a 7 day period. They were 
then transferred from their individual screen bottomed 
cages to individual metabolism cages, and their urine 
collected during a 24 hour fast under cold stress. The 
urine from the rats within a group was pooled and the crude 
FMS extracted, weighed, and bioassayed in vitro for lipoly-
tic activity. Several approaches were employed for testing 
the lipolytic activity of the FMS preparations. 
Depending upon group mean weight just prior to the 24 
hour fasting period under cold stress, the assay data col-
lected on each individual rat group was placed in one of 
three weight, hence age, categories: (Category 1) body 
weight range, "150-250" grams; Mean age, 7 weeks: (Cate-
gory 2) Body weight range, "250-350" grams; Mean age, 14 
weeks: (Category 3) Body weight range, "350-450" grams; 
Mean age, 18 weeks or greater. 
Performance of in vitro bioassay, initially by the 
method Duncombe, afforded a convenient and rapid measure-
ment of the quantitative release of FFA as index of the 
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lipolytic activity of the FMS preparation obtained from 
each rat group. Table 9 shows the data obtained for each 
of the three defined categories in terns of free fatty 
acids released from epididymal fat pads of the rats 130-
150 grams in weight in a medium of Krebs-Ringer phosphate 
buffer (pH 7.4) containing 4% bovine serum albumin. Analy-
sis of variance showed the observed variation between acti-
vity values of each of the categories to be significant 
(P < 0.05). Student t-tests determined which specific 
categories show significance and at which level (Category 
I vs. II, P < 0.01; Category II vs. III, P = 0.05). 
Decreasing levels of significance in lipolytic activity 
are noted in association with increasing weight and age of 
rats from which the FMS is isolated. 
After initial bioassay in vitro, the following ~n 
vitro bioassays utilized epididymal fat cell suspensions. 
Considerably increased lipolysis by FMS target cells was 
observed as reflected by sizably increased amount of FFA 
released in response to the same preparations of FMS. 
These results are attributable to an increased sensitivity 
of isolated fat cells as opposed to intact fat pads to 
lipolytic agents. Data on these bioassays depict the 
effect of weight and age on total urinary excretion of FMS 
under three classifications, the effect of weight and 
age on FMS bulk excretion (Table 10), FMS specific 
lipolytic activity (Table ll) and FMS total lipolytic acti-
vity (Table 12). Data in each of the three tables are 
TABLE 9 
ResponseofAdipose Tissue to FMS Isolated from Rats of Different Weight and Age 
Category Weight Range (gm)_ 
Mean Age 
(wks) 
FFA* 
(umoles) 
P vs Difference 
Betw·een Category Means 
p vs 
Control 
Control 0.361 + 0.03** 
I 
II 
III 
* 
** 
-
150-250 7 0.519 + 0.05 p < 0.001 
- p < 0.01 
250-350 14 0.435 + 0.02 p < 0.01 
- p = 0.05 
350-450 18 0.390 + 0.005 p < 0.3 
-
Expressed as umoles free fatty acids (FFA) released by 100 micrograms of test 
material acting on 250 milligrams of rat epididymal adipose tissue for 3 hours 
at 37°c. 
Mean + standard deviation of the combined group means. 
I-' 
0 
w 
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TABLE 10 
Effect of \"'eight and Age on the Bulk Excretion of FMS 
Body Mean 
Weight Approx. Bulk Excretion 
Category Age (mg/animal) 
(gm) (wks) Category 
I. 150-250 7 1.9 
M 
188 
G l) 152 R 0.6 
0 2) 193 0.2 
u 3) 233 2.5 
p 4) 174 4.1 
s 
II. 250-350 14 2.0 
M 
301 
G l) 260 0.2 
R 2) 329 2.8 
0 3) 329 1.4 
u 4) 253 4.1 
p 5) 336 1.7 
s 
III. 350-450 18 4.2 
M 
398 
G 
R l) 379 0 5.0 
u 2) 416 3.3 
p 
s 
TABLE 11 
Effect of Wei,ght and Age on the Specific Activity of FMS 
Body 
Weight 
Category 
(gm) 
Approx. 
Control 
I. 150-250 
M 
188 
1) 152 
2) 193 
3) 233 
4) 17 4 
Age 
(wks) 
7 
IT. 250-350 14 
m. 
M 
301 
1) 260 
2) 
3) 
4) 
5) 
350-450 
H 
398 
1) 
329 
329 
253 
336 
379 
2) 416 
18 
Specific Actlvity 
(umoles) 
Group Category 
FFA Glycerol FFA Glycerol 
11.69 
*11. 59 
11.56 
11.38 
12.20 
*10.67 
10.52 
10.98 
10.57 
11.68 
11.04 
2.42 
2.29 
2.15 
2.42 
2.15 
2.08 
2.15 
2.22 
2.02 
1. 88 
10.02 
11.68 
10.91 
10.35 
1. 61 
2.32 
2.15 
1.95 
p vs 
Difference Between 
Category Means 
f2FA Glycerol 
p vs 
Control 
FFA Glycerol 
P<O.OOl P<O.OOS 
P<O.Ol P<O.OS 
.--1 _J P<0.025 P<O.OOl 
P<O.OO 
P<O.OS P<O.Ol 
-I .J P<0.30 P<O.OS 
*10.39 
10.48 
*10.26 
10.26 
-- ... f-J 
Specific Activity is expressed as umoles FFA and glycerol released by 100 ug of FMS 0 
acting on rat epididymal fat cell suspension equivalent to 1 gram of lipid. ~ 
* Two sets of determinations were run on these rat groups. 
TABLE 12 
Effect of Weight and Age on the Tofal Activity of FMS 
Body 
Weight 
Category 
(gm} 
Approx. 
Age 
(wks) 
I. 150-250 7 
M 
188 
1) 152 
2) 193 
3) 233 
4) 174 
II. 250-350 
M 
301 
1} 260 
2) 329 
3} 329 
4) 253 
5} 336 
III. 350-450 
M 
398 
1} 379 
2) 416 
14 
18 
Total Activity 
umoles/animal 
Group Category 
FFA Glycerol FFA Glycerol 
7.0 
*2.3 
2.3 
28.5 
50.0 
*2.1 
2.1 
30.7 
14.8 
47.8 
18.8 
*52.0 
52.4 
*33.9 
33.9 
1.5 
0.5 
5.4 
9.9 
.43 
5.8 
3.0 
9.1 
10.1 
6.2 
18 4 
19 5 
43 8 
Total Activity, calculated as weight of extract (mg) 
times specific activity. 
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* Two sets of determinations were run on these rat groups. 
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delineated in terms of categorical means representative of 
the average of the sum of individual group means comprising 
each of the three categories, and mean bulk excretion level 
(Table 10), mean specific (Table 11) and total (Table 12) 
lipolytic activities for every animal group contained within 
each of the defined weight-age categories. 
Analysis of variance revealed a significant variation 
in the degree of soecific lipolytic activity amongst the 
three lots of FMS from the three defined weight-age categor-
ies, whether FFA (P < 0.001) or glycerol (P < 0.01) release 
was employed as index of FMS lipolysis. Thereupon, t-tests 
were conducted to ascertain at what significance level which 
specific categories are significantly different in lipolytic 
activity. Weight categories I and II were significantly 
different in specific lipolytic activity for both FFA and 
glycerol released by the isolated epididymal fat cells (FFA, 
P < 0.01; glycerol, P < 0.05). Beb1een categories II and 
III the difference in F~1S lipolysis showed significance for 
both indexes of lipolysis (FFA, P < 0. 0 5; glycerol, P < 0. 01). 
Regarding the specific activity data, Students t-test 
performed on the mean specific lipolytic activity of means 
(the mean of the sum of the 11 group means) and the Controls 
showed a significant difference in lipolytic activity for 
both indexes of lipolysis (FFA, P < 0.01; glycerol, P < 
0.001). 
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Figure 5 illustrates the relationship between 'Specific 
and Total Activity of FMS', dependent upon \veight and age 
of the rat from which FMS is isolated. FFA and glycerol 
release are expressed in terms of umoles released per 100 
micrograms of FMS acting upon epididymal fat cell suspen-
0 
sion equivalent to 1 gram of cell lipid for 3 hours at 37 C. 
Substantiated via the Analysis of Variance and Students 
t-test performed on the specific activity data obtained for 
each of the 11 rat groups, the histogram depicts a signifi-
cant difference in Specific Lipolytic Activity amongst the 
three defined weight-age range categories: ( 1) Weight rang~ 
150-250 grams; Mean age, 7 weeks; (2) Weight range, 250-
350 grams; Mean age, 14 weeks; (3) Weight range, 350-450 
grams; Mean age 18 weeks or greater. In addition, the histo-
gram illustrates a highly negative correlation, to the same 
degree of significance as established by the already per-
formed statistical analyses, existing between FMS Specific 
Activity and increasing weight-age of the rat. 
A more pronounced effect exists between FMS Total 
Activity (Total Activity, calculated as weight of FMS 
extracted from the rat urine times specific activity) and 
increasing weight-age of the rat. However, for both indexes 
of lipolytic activity, instead of a highly negative correla-
tion between increasing weight and age of the rat, the 
correlation is highly positive. 
Decreasing 'Specific Activity' with increasing 'Total 
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Figure 5. Variation of Specific and Total Lipolytic 
Activities with Rat Body Weight and Age. 
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Activity' was found in the 11 rat groups with increasing 
weight and age. The greatest specific activity was found 
in the FMS isolated from rats weighing 150-250 grams with 
a mean age of 7 weeks (Category 1). In contrast, total 
activity was found to increase with increasing weight and 
age. In comparison with rats weighing 150-250 grams and 
7 weeks in age (Category 1), for rats weighing 350-450 
grams with a mean age of 18 weeks or greater (Category 3), 
the total activity doubled, both for FFA and glycerol 
indexes of lipolysis. 
In conjunction with the in vitro bioassays utilizing 
the increased sensitivity of isolated adipocytes, examina-
tion of the lipolytic response of adipocytes to FMS in the 
terms of their cell number and-size was studied. Table 13 
expresses in terms of FFA and glycerol release per 10 6 
cells, specific lipolytic activity for each of the defined 
weight-age categories. It will be observed that fat cells 
have the greatest apparent sensitivity to FMS that is 
isolated from rats ranging 150-250 grams in weight. As the 
rats increased in weight and age the lipolytic response of 
the adipocytes to their FMS extracts apparently decreased. 
Cellularity was determined on every cell suspension 
prepared for in vitro bioassay. Figure 6 shows the combined 
cell diameter frequency distributions of the individually 
prepared fat cell suspensions used in the various bioassays. 
TABLE 13 
Response of Adipocytes to FMS Isolated from Rats of Different vJeight and Age 
Weight Age FFA Glycerol 6 6 Category Range (gms) (wks) (umoles/10 cells/hr)* (umoles/10 cells/hr)* 
-3 ** -3 
Control 195.61 X 10 + .009 31.26 X 10 + .008** - -
1 150-250 7 227.30 X 10-3 + .005 -3 45.04 X 10 + .002 
2 250-350 14 -3 212.79 X 10 + .008 -3 41.74 X 10 + .001 
3 350-450 18 202.89 X 10-3 + .002 -3 37.86 X 10 + .001 
A Coulter electronic counter was used to count and size the suspended epididymal 
fat cells. Cell preparations were made only from rats weighing between 130-150 
gms. The mean diameter of the fat cells in this weight range, obtained by 
averaging the mean diameters from the individual cell suspensions used in the 
various assays, came to approximately 44 + 0.4 u. 
* Micromoles free fatty acids/glycerol released per 10 6 target cells by 100 ug 
of test material acting on rat epididymal adipose tissue fat cells equivalent to 
1 gram of lipid in a medium of Krebs-Ringer phosphate buffer at 37°C for 1 hour .. 
** Mean + standard deviation of the combined group means. 
1-' 
f-' 
f-' 
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Figure 6. Frequency Distribution of Adipose Cell Diameters. 
Mean diameter is representative of 985728 free 
fat cells liberated by collagenase incubation 
from epididymal fat pads of 130-150 gm rats. 
Midpoint of classes and class limits and mean 
cell diameter + standard deviation are shown. 
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The mean cell dianeter + standard deviation of ~he co~bined 
cell diameter frequency distributions came to 44 + 10 ~· 
The mean diameter + standard error of the mean of the 
combined freq~ency distributions is 44 + 0.17 ~. 
Purification of FMS by Ultrafiltration 
Thirty ~ale albino rats of the Sprague-Dawley strain 
were placed for 7 days on the high fat diet described pre-
viously. Their urine was then collected under a 24 hour 
fast at the cont~olled temnerature of 15°C. The collected 
urine was pooled, and crude FMS was extracted by the four 
stage extraction process already described. Preparations 
of crude F~S were obtained from numerous urine collections 
from a number of groups of animals. 
After assaying, on an individ~al basis, each lot of 
crude ~~S obtained per 30 animals, all of the individual 
preparations of crude F~S were pooled by dissolving them 
in deionized water, and the solution was lyophilized. 
The pooled crude FMS preparation was then divided into 
multiple units, each unit being carried through the ultra-
filtration proce0ure, but separately. The results given in 
Table 14 present the mean lipolytic activities for the 
various fractions obtained from a number of these units that 
were carried through each stage of ultrafiltration. The 
aqueous solution of crude F~S of each unit was first ouri-
fied by means of ultrafiltration using a PM-10 Diaflo 
mer1brane. The filtrate and the residue were each freeze-
Table 14 
Purification of FMS by Ultrafiltration 
Source Amount Material Amount Lipolytic Activity* P vs Source Total Activity** 
(mg) (mg) FFA (umoles)*** FFA (umoles) 
Control .361 + 0.03 
-
Urine Crude FMS .454 + 0.01 
Crude 439 P.H-10 271 .496 + 0.01 p < 0.001 134 
-FMS Filtrate 
PM-10 156 .353 + 0.14 p < 0.0025 55 
Residue 
Pt1-10 256 UM-2 201 .326 + 0.02 p < 0.001 66 
-Filtrate Filtrate 
UM-2 54 .578 + 0.07 p < 0.001 31 
-Residue 
* Expressed as umoles free fatty acids (FFA) released by 100 ug of test material 
acting on 250 mg rat epididymal adipose tissue for 3 hours at 37oc. 
** 'Total Activity', calculated as weight of extract (mg) times 'Lipolytic Activity'. 
*** Mean + standard deviation, five determinations, with the exception of the 
'Control' which is based on ten sets of five determinations. 
1-' ,_. 
~ 
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dried and bioassayed in vitro for lipolytic activity by 
use of the assay utilizing the quantitative release of FFA 
from e9ididymal fat pads. 
The mean results of these analyses, show that the 
active material was associated wit~ the P~-10 filtrate. 
This filtrate in turn was ultrafiltered in the same manner 
through a m-1-2 Diaflo membrane. Both t~e filtrate and the 
residue were again lyo9hilized and assayed in vitro for 
lipolytic activity. The activity \.Vas found to be associated 
with the Uiv1-2 residue. These findings are in agreement ;.,ri·th 
those of Kwok, 1974. 
Further ourification by ultrafiltration was accomplis~1-
ed by using a D~-5 Diaflo membrane which was substituted for 
the UH-2 mer:ibrane in one inst:ance, and in another, incor-
poraJced into t~e 9urificat.ion protocol (K\·lOk, 1974) afJcer 
ultrafiltration by the P~·1-10 and U!1-2 menbranes. Fron the 
results of these analyses shown in Table 15 it is apparent 
that the active material ~vas associated tvith the D:-1:-5 resi-
due under bot~ of these ultrafiltration routes. 
Crude FMS carried tl1roug~1 the U~-2 ultrafiltrative 
yielded a product (UM-2 residue) with an increased in vitro 
specific activity of about 27% (Table 15). Nhen D~1-5 :.11 tra-
filtration was applied to this residue, the soecific acti-
vity of t~1e product (D!-1-5 residue) \vas about 60% greater 
than that of crude FMS. When UM-2 ultrafiltration was 
omitt:ed and the P?1-10 fj_ltrate was subjec·ted directly to 
TABLE 15 
Purification of FMS by DM-5 Ultrafiltration 
Source Amount Material 
(mg) 
PM-10 15 
Filtrate 
UM-2 
Residue 
54 
Control 
PM-10 
Filtrate 
DM-5 
E'iltrate 
m.1-5 
Residue 
UM-2 
Residue 
DM-5 
Filtrate 
DM-5 
Residue 
Amount 
(mg) 
15 
11 
4 
10 
44 
Lipolytic Activity* 
FFA (umoles)*** 
.361 + 0.03 
.496 + 0.01 
.413 + 0.004 
.941 + 0.03 
.578 + 0.07 
.466 + 0.08 
.728 + 0.01 
P vs Source 
p < 0. 001 
p < 0.001 
p < 0.0125 
p < 0.001 
Total Activity** 
FFA (umoles) 
7.4 
4.5 
3.8 
31 
4.7 
32 
* Expressed as umoles free fatty acids (FFA) released by 100 ug of test material 
acting on 250 mg rat epididymal adipose tissue for 3 hours at 37°C. 
** 'Total Activity', calculated as weight of extract (mg) times 'Lipolytic Activity'. 
***Mean + standard deviation, five determinations, with the exception of the 'Con-
trol'-which is based on ten sets of five determinations. 1-' 1-' 
0) 
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DM-5 ultrafiltration, the specific activity of the product 
(DM-5 residue) was about 107% greater than that of crude FMS. 
This difference in percentage increase in specific 
lipolytic activity per unit \veight of crude F.MS between 
the two D~-5 residues prepared via alternate routes of 
ultrafiltration may be due to the increased time spent by 
crude FMS in aqueous solution in the process of ultrafil-
tration, viz. a three step ultrafiltration procedure as 
opposed to a two step ultrafiltration. Beaton (1964) found 
a significant loss of activity with FMS in aqueous solution 
(pH 3.1) in a 24 hour period with no marked further loss 
between 24 and 48 hours. 
Another possible explanation is that an artifact in 
the type of membrane used during ultrafiltration may cause 
a structural change in the FMS fraction being ultrafiltered. 
For example, DM-5 Series membranes are less hydrophilic 
than UM membranes and have exceptional resistance to deter-
gents, salts, and phosphates, which affect the UM structure. 
Since the increase in time spent by FMS in aqueous solution 
is relatively small when the ultrafiltration sequence in-
cludes the UM-2 ultrafiltration step, the latter possibilit¥ 
appears to be a more plausible explanation. 
In making a comparison of the total activity data, 
shown in Table 15, between the UM-2 residue and its products 
of DM-5 ultrafiltration, it is noted that the total activity 
of the UM-2 residue was 31 and of the products was 4.7 
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(ultrafiltrate) and 32 (residue). The sum of the total 
activities of products (36.7) exceeds that of the original 
UM-2 residue. The same type of observation is noted in 
Table 15 when comparing total activity data between the 
PM-10 filtrate and its products of DM-5 ultrafiltration. 
These discrepancies are not accounted for. They may be due 
to the removal of inhibitory substances or to the freeing 
of active material from its bound form during the DM-5 
ultrafiltration process. 
Ultrafiltration via the DM-5 membrane added informa-
tion as to the approximate molecular weight of FMS. Al-
though ultrafiltration membranes do not yield quantitative 
molecular weight fractionation, their rejection character-
istics are suitable for separation of proteins into reason-
ably accurate molecular weight ranges. 
In agreement with the work of Kwok (1974), fractiona-
tion of crude FMS into substances greater than and less 
than 10,000 in molecular weight by PM-10 ultrafiltration 
and subsequent bioassays indicated that the fraction with 
molecular weight greater than 10,000 did not possess fat-
mobilizing activity, (Table 14). When the active fraction, 
the PM-10 filtrate, was further fractionated in the same 
manner through a UM-2 Diaflo membrane, with a cut-off at 
1,000 in molecular weight, the active material was associ-
ated with the UM-2 residue. Thus, active material isolated 
from rat urine has a molecular weight between 1,000 to 
10,000 daltons. 
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The newly patented DM-5 Diaflo membrane has a cut-off 
at 5,000 in molecular weight. Fractionation of the PM-10 
filtrate by DI1-5 ultrafiltration, followed by subsequent 
in vitro bioassay indicated that the fraction with molecu-
lar weight greater than 5,000 (DH-5 residue) possessed the 
fat-mobilizing activity (Table 15). 
Fractionation of crude FMS first by PM-10 ultrafiltra-
tion followed by UM-2 ultrafiltration produced a substance 
containing fat mobilizing activity with a molecular weight 
between 1,000 to 10,000. When this material with fat 
mobilizing activity was then fractionated into substances 
greater than and less than 5,000 in molecular weight by 
use of the DM-5 Diaflo Bembrane, subsequent in vitro bio-
assay indicated that the fraction with molecular weight 
greater than 5,000 (DM-5 residue) possessed the greatest 
fat mobilizing activity per unit weight. These data 
approximate F.HS as isolated from rat urine to have a 
molecular weight between 5,000 to 10,000 daltons. 
Consideration of the results in Table 15 indicatethat 
even though both routes of ultrafiltration via the DH-5 
Diaflor membrane have indicated through subsequent in vitro 
bioassay that the DM-5 residues possessed the fat mobilizing 
activity, the DM-5 filtrate obtained from ultrafiltration 
of the UM-2 residue, contained lipolytic activity similarin 
degree to that of crude FMS. In contrast, the inactive 
fractions, namely, the PM-10 residue and the UM-2 filtrate 
obtained from PM-10 and UM-2 ultrafiltration, possessed 
lipolytic activity of the same magnitude as that of the 
control sample. This suggests the possibility that the 
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FMS isolated from rat urine not only has a molecular weight 
between 5,000 to 10,000, but that the molecular weight of 
the substance containing fat mobilizing activity may be 
close to 5,000. Some of the fat mobilizing substance may 
be leaking through the other side of the DM-5 Diaflo-
membrane, that has a cut-off of 5,000 in molecular weight, 
during the ultrafiltration process. 
Purification of FMS by Gel Filtration 
Kekwick and Pawan (1967) reported the achievement of 
some purification of FMS by passage of an ultrafiltrate, 
derived from ultrafiltration with a Visking Dialysis mem-
brane, through a column of Sephadex G-50 directly followed 
by passage through a column of BioGel P-10, and pooling the 
fractions which exhibited maximal U-V absorption. When in 
our laboratory, a 0.01% aqueous solution of UM-2 residue 
was subjected to gel filtration employing these same two 
gel types, in the same sequential arrangement, the elution 
peak and the activity peak representing the transmittance 
of the effluent at 280 nm were found to coincide with each 
other (Kwok, 1974). 
To date, there is no report of an elution profile, 
data, or any descriptive information, on the purification 
of FMS by gel filtration employing the exclusive use of 
BioGel P-18 or Sephadex G-50. Nor has an explanation 
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or reason been given as to why the purification of FMS by 
gel filtration necessitates passage of the source material 
through these two functionally similar gel types. Based 
on the estimated molecular weight of FMS, both BieGel P-10 
and Sephadex G-50 cover the same recommended fractionation 
range desirable for optimum separation and/or purification 
of FHS. 
Consequently, consideration was given to the possibil-
ity of whether or not efficient gel chromatographic purifi-
cation of FMS could be achieved with the elimination of one 
of these chromatographic columns. 
BieGel P-10 has an exclusion limit 10,000 less in 
molecular weight than Sephadex G-50 and covers the approxi-
mate molecular weight range of 1,500 to 20,000 over which 
separation of molecular substances, contained within the 
UM-2 residue {1,000 to 10,000 in molecular weight), could 
be expected to occur. Therefore, initial column chroma-
tography was performed by passage of the UM-2 residue 
through a prepared column of BieGel P-10 with elution by 
deionized water. 
The elution profile of the UM-2 residue on BieGel P-10 
appears in Figure 7. Fractions 6 to 9 and 20 to 23, corre-
sponding to elution Peak I and Peak II respectively, were 
each pooled, lyophilized and assayed in vitro for lipolytic 
activity by measuring the quantitative release of FFA from 
rat epididymal fat pads. As can be seen in Table 16 Peak I 
122 
.07 - - 85 
E .05 - Ql () 
- 90 c c • .. 
0 .. 
II) E N 
.03 1- Ill • c () Ill 
c 
- 95 ~ J I" 
.. 0 0 
.! 
.01 - ~ c 
100 
20 4
1
0 60 80 1 0 
Fraction No. 
. 07 85 
E • () 
c. OS c 
0 90 • .. 
II) 
= N E 
• Ill lo) c 
c .03 • 
• i= 
.a 95 .. 
i 
-
.a 0 
c 
.01 ~ 
100 
0 20 40 60 80 100 
Fraction No. 
Figure 7. Top: Gel Filtration of UM-2 residue on Bio-Gel 
P-10. Bottom: Gel Filtration on Sephadex G-50 
followed by Bio-Gel P-10 of a combined prepara-
tion of Peak I and Peak II previously fractionat-
ed by passage of UM-2 residue through the column 
of Bio-Gel P-10 (top). In both procedures, top 
and bottom: column size 2.5 x 45 em; eluant de-
ionized water; temperature 5°C; fraction size 
5 ml. Percent transmittance monitored at 280 nm. 
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TABLE 16 
Purification of FMS by Gel Filtration 
Material 
BioGel P-10 
Effluent FFA, umoles* P vs. Source 
Control 0.361 + 0.03 
UM-2 Residue 0.578 + 0.07 
UM-2 Residue Peak I 1.120 + 0.05** p < 0.001 
Peak II .355 + 0.03 p < 0.001 
DM-5 Residue*** 0.835 + 0.02 
DM-5 Residue Peak I 1.922 + 0.03 p < 0 0 001 
* Expressed as umoles free fatty acids (FFA) released by 
100 ug of test material acting on 250 mg rat epididymal 
adipose tissue for 3 hours at 37 degrees centigrade. 
** Mean + standard deviation, five determinations. 
***Composite mixture of the two DM-5 residues cited in 
Table 15, 50% (w/w). 
contained lipolytic activity. The second peak possessed 
no lipolytic activity. 
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The in vitro specific lipolytic activity revealed 
approximately two fold purification of the fat mobilizing 
substance (FMS) contained within the UM-2 residue. Purifi-
cation of crude FMS through gel filtration of UM-2 residue 
on the BioGel P-10 column revealed a product whose specific 
lipolytic activity had increased by 150%. 
Gel filtration of the UM-2 residue through the pre-
pared column of BieGel P-10 resulted in two major peaks, 
only one of which, upon in vitro bioassay, contained lipid 
mobilizing activity. However, passage in our laboratory 
(Kwok, 1974) of the same material (UM-2 residue) or passage 
by Kekwick and Pawan (1967) of their material, of similar 
fat mobilizing content (Visking Dialysis membrane, ultra-
filtrate), through Sephadex G-50 and BieGel P-10 in sequen-
tial arrangement, demonstrated the elution of a single 
major peak coinciding with the activity peak. In an 
attempt to provide more information concerning this dif-
ference between elution patterns, the following compara-
tive gel chromatographic procedure was performed. 
The remainder of the lyophilized material from Peak I 
and the remainder of the lyophilized material from Peak II, 
were recombined in equal proportions (w/w), and dissolved 
in deionized water. With deionized water as eluant, this 
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aqueous mixture was subjected to gel filtration by passage 
through a prepared column of Sephadex G-50, directly 
followed by passage through the same BioGel P-10 column 
employed in the previous UM-2 chromatographic procedure. 
As can be seen in Figure 7, the elution profile contained 
only one major peak. 
This resultant difference between elution profiles on 
UM-2 residue filtration via exclusive use of the BioGel P-
10 column and, upon recombination of the two UM-2 residue 
eluant peak fractions from this BioGel column, the elution 
profile on their refiltration via the sequential arrange-
ment on Sephadex G-50 and BioGel P-10, does provide suppor-
tive evidence for better resolution of the component sub-
stances contained within the UM-2 residue. This is demon-
strated by the two separate peaks on the UM-2 residue 
BioGel P-10 elution profile, in contrast, to their resul-
tant elution profile after their recombination and sequen-
tial refiltration through Sephadex G-50 directly followed 
by BioGel P-10 which contains only one major peak. 
The use of BioGel P-10 may provide better purifica-
tion of the fat mobilizing substance contained within the 
UM-2 residue than filtration through Sephadex G-50 directly 
followed by BioGel P-10. This purification improvement is 
suggested by the appearance of two separate peaks on the 
BioGel P-10 elution profile, of which only one contained 
lipolytic activity. 
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However, the disappearance of the second major peak from 
the elution profile resulting from the sequentially 
arranged columns may be due to the adsorption of this in-
active substance, represented as the second peak (Fig. 7), 
onto the Sephadex G-50 column before entrance of the efflu-
ent onto the BioGel P-10 column. As a result, an insuffi-
cient quantity of this inactive component, if any, would be 
available to produce a major peak upon its final elution 
off of the sequentially following BioGel P-10 column. The 
same end would be accomplished; this being the removal of 
this inactive substance from the UM-2 residue. 
The possibility also exists, that this inactive sub-
stance cannot be dissociated from active FMS by gel filtra-
tion under the experimental conditions imposed by the se-
quential arrangement of the two gel types. Interpretation 
has been made subject to inherent limitation because, upon 
completion of the sequential gel filtration procedure, an 
insufficient quantity of material was available to provide 
a quantitative bioassay. However, upon attainment of the 
experimental results on the DM-5 residue gel filtration 
procedure next to be described, further pursuit of the se-
quential filtration procedure was not an utmost necessity. 
Beaton et al. (l966b) upon fractionation of their 
ultrafiltrate derived from ultrafiltration under a Visking 
cellulose tubing {pore size 24 R) on Seohadex G-25 {frac-
tionation range 1,000 to 5,000 in molecular weight), demon-
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strated the presence of three active fractions associated 
with the ultrafiltrate. In our laboratory Kwok (1974) 
passed an aqueous solution of UM-2 residue through a 
Sephadex G-25 column with elution by distilled water and 
found the activity to be associated only with the first 
ten 5 ml fractions. 
The results obtained by our laboratory (Kwok, 1974) 
suggested that the lipolytically active material may be 
approximately equal to, or greater than 5,000 in molecular 
weight. Further evidence was provided in support of this 
hypothesis, when after DM-5 ultrafiltration (cut-off 5,000 
in molecular weight) of the PM-10 filtrate or the UM-2 
residue, the lipid mobilizing substance was found to be 
primarily contained within the DM-5 residue. 
As a consequence of these experimental findings, this 
DM-5 residue was subjected to further purification by gel 
filtration, with elution by deionized water, using the Bio-
Gel P-10 column. The elution pattern of the DM-5 residue 
on BioGel P-10 appears in Fig. 8. 
Fractions 19 through 22, corresponding to the elution 
peak were pooled, lyophilized, and the residue assayed in 
vitro for lipolytic activity by measurement of the quanti-
tative release of FFA from rat epididymal fat pads. As can 
be seen in Table 16, there is a significant difference in 
lipolytic activity between the DM-5 residue and the sub-
stance of the elution peak (p < 0.001). In vitro specific 
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Figure 8. Gel Filtration of DM-5 Residue on Bio-Gel P-10. 
Column-size 2.5 x 45 em; eluant deionized water; 
temperature 5°C; flow rate 1.8 ml/minute; frac-
tion size, 5 ml. Percent transmittance monitored 
at 280 nm. 
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lipolytic activity increased 130% per unit weight of the 
composite DM-5 residues obtained via DM-5 ultrafiltration. 
The extension of the purification process to include 
molecular sieve chromatography exclusively via BioGel P-10 
with the elimination of Sephadex G-50, enhanced the specific 
lipolytic activity of crude FMS on a weight-for-weight 
basis by 147% for the UM-2 residue and 323% for the DH-5 
residue. 
Isoelectric Focusing of FMS 
FMS at various stages of its purification was subject-
ed to isoelectric focusing. Fig. 9 depicts the UV absorp-
tion curve and superimposed pH curve obtained by eluting 
and subsequent monitoring of the electrofocused FMS Fraction 
I, FMS Fraction II, and FMS Fraction III bands and an un-
named band associated with FHS Fraction III from the elec-
trofocusing apparatus in which the FMS UM-2 residue prepara-
tion has been resolved. The electrofocusing run required48 
hours. The pH of the collected fraction at the elution 
peaks corresponds to the pi of the various resolved FMS 
Fractions. The electrofocusing was run at 4°C. The pH 
readings were determined at 4°C. 
Fig. 10 depicts the electrofocused FMS Fraction I and 
FMS Fraction II bands from the apparatus in which the FMS 
DM-5 residue preparation has been resolved. 
Fig. 11 shows resolution of the FMS Fraction I andFMS 
Fraction III bands from the active eluant peak fractions 
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Figure 9. Separation of FMS UM-2 Residue by LKB 8100 Ampholine Electrofocusing 
Column in Which FMS Fraction I, FMS Fraction II, and FMS Fraction III 
Have Been Resolved. The curve with peaks shows the absorption of the 
eluate at 280 nm. The steadily increasing curve is a plot of the pH 
gradient superimposed. Isoelectric point values shown at the various 
peaks were read from the pH gradient curve. 
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Figure 10. Separation of FMS DM-5 Residue by LKB 8100 Ampholine Electrofocusing 
Column in Which FMS Fraction I and FMS Fraction II Have Been Resolved. 
The curve peaks shows the absorption of the eluate at 280 nm. The 
steadily increasing curve is a plot of the pH gradient superimposed. 
Isoelectric point values shown at the various peaks were read from 
the pH gradient curve. 
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Figure 11. Separation of the Active Eluant Peak Fraction Obtained from Passage 
of FMS UM-2 Residue Through a Sephadex G-50 Bio-Gel P-10 Column by 
LKB 8100 Ampholine Electrofocusing Column in Which FMS Fraction I 
and FMS Fraction III Have Been Resolved. The curve with peaks 
shows the absorption of the eluate at 280 nm. The steadily increas-
ing curve is a plot of the pH gradient superimposed. Isoelectric 
point values shown at the various peaks were read from the pH gradi-
ent curve. 
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obtained from passage of FMS UM-2 residue through a Sepha-
dex G-50 BieGel P-10 column. FMS Fraction III is directly 
followed by three unidentified bands corresponding to the 
pi of 5.3, 5.4, and to the pi of 6.1. These bands present 
though not shown on the UM-2 residue electrofocusing map 
(Fig. 9) proved to be non-active lipolytically. 
No matter which FMS preparation is resolved, the highly 
sensitive resolving power of the isoelectric focusing tech-
nique clearly demonstrates that the FMS Fractions (lipoly-
tically active bands) will always end up at the point in 
the gradient where the pH is equal to the isoelectric point 
of the protein component. 
In Vitro Bioassay of FMS Fraction I, FMS Fraction II and FMS 
Fraction III 
All electrofocused bands eluted from the electrofocus-
ing column were initially assayed in vitro for lipolytic 
activity by the very rapid and simple modified method of 
Duncombe (1964). One hundred micrograms of test material 
was incubated with 250 milligrams of rat epididymal fat pad 
in a medium of Krebs-Ringer phosphate buffer containing 4 
per cent bovine serum albumin. 
Table 17 shows the results for the initial bioassay of 
FMS Fractions I, II, III, and unidentified bands. For com-
parative purposes, the results are expressed in terms of 
umoles FFA released per gram of epididymal fat pad upon incu-
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TABLE 17 
Lipolytic Activity of Electrofocused Bands from the 
Electrofocusing Column in which FMS Preparations 
Have Been Resolved 
No. of 
Material Determinations 
Control 15 
FMS Fraction I 15 
FMS Fraction II 10 
FMS Fraction III 5 
Unidentified Bands 5 
(Include those of: 
pi 5.3, 5.4 and 6.1) 
In Vitro* 
Lipolytic Activity 
1.44 + .12** 
7.24 + .38 
7.29 + .26 
7.14 + .54 
1.43 + .37 
* Expressed as umoles free fatty acids released by 100 
ug of test material acting on 1 gram of rat epidicymal 
adipose tissue from 3 hours at 37°C. 
** Mean + standard deviation, five determinations, compo-
site of data obtained from lipolytic assays of the frac-
tions from the three electrofocusing profiles. 
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bation for 3 hours at 37oc being acted upon by 100 micro-
grams of test material. It is observed that there is no 
difference in lipolytic activity between FMS Fraction I, II 
and III. 
FMS Fractions I, II, and III were further subjected to 
in vitro bioassay utilizing the more specific assay system 
which employs isolated fat cells for direct analysis on tar-
get cell-FMS interaction. Table 18 expresses in terms of 
FFA release the lipolytic response of FMS target cells to 
100 micrograms of FMS Fraction I, FMS Fraction II, and FMS 
Fraction III on a per unit cell lipid basis. 
The lipolytic activity of each of the three FMS frac-
tions was significantly different from that of crude FMS 
(p < 0.001}. The lipolytic activity of the crude FMS was 
significantly different from that of the Controls (p < 
0.05). Analysis of variance (F-test) on FMS Fraction I, 
II, and III shows that on a per unit cell-lipid basis the 
lipolytic activity does not differ significantly amongst the 
three fractions of FMS (p > 0.2). 
Table 19 expresses on a per unit cell-lipid basjs the 
lipolytic response of FMS target cells to 100 ~icrograms of 
FMS Fraction I, FMS Fraction II, and FMS Fraction III in 
terms of glycerol release. Whereas net changes in the 
amount of free fatty acids released into the incubation 
medium represent the difference between the amount formed 
-... 
by lipolysis and the amount reesterified, glycerol is a more 
probable reflection of the rate of lipolysis. The correla-
TABLE 18 
FFA Release as Index of Lipolytic Activity of FMS 
at the Initial and Final Stages of Purification 
No. of In Vitro* 
FHS Determinations LipoT:Yt1c Activity 
Control 6 10.3 + 0.55** 
Crude Fr'iS*** 15 11.0 + 0.60 
Fraction It 5 31.2 + 0.71 
Fraction II 5 31.8 + 0.56 
Fraction III 5 31.3 + 0.74 
* Expressed as umoles free fatty acids released by 100 
ug of test material acting on rat epididymal adipose 
tissue fat cell suspension equivalent to 1 gram of 
lipid for 3 hours at 37°C. 
** Mean + standard deviation, for the given number of 
determination?. 
*** Composite of FMS extracted from each of the three 
weight-age categories. 
t Composite fractions from three isoelectric focusing 
profiles. 
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TABLE 19 
Glycerol Release as Index of Lipolytic Activity of 
FMS at the Initial and Final Stages of Purification 
No. of In Vitro* 
FMS*** Determinations Lipolytic Activity 
Control 6 1.16 + 0.00** 
Crude FI-1S 10 2.18 + 0.16 
Fraction I 5 9.41 + 0.03 
Fraction II 5 9.35 + 0.07 
Fraction III 5 9.36 + 0.01 
* Expressed as umoles of glycerol released by 100 ug 
of test material acting on rat epididymal adipose 
tissue fat cell suspension equivalent to 1 gram of 
lipid for 3 hours at 37oc. 
** Mean + standard deviation, for the given number of 
determinations. 
***FMS material as described in Table 18. 
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tion between the rate of lipolysis on each of the three 
FMS Fractions for these two criteria of lipolytic activity 
is significantly positive, showing no reesterification is 
taking place. 
Adipose tissue cellularity was determined on every 
fat cell suspension prepared for bioassay by the use of the 
Coulter electronic counter. Table 20 expresses in terms of 
glycerol and FFA release per 106 target cells, the lipoly-
tic activity of FMS Fraction I, II and III. 
Determination of Total Protein Content of FMS Fraction I, 
FMS Fraction II, and FMS Fraction III 
The protein content of the three FMS Fractions \vere 
measured using the method of LO\'lry et al. (1951). Table 
21 displays the data obtained for these analyses. 
Specific lipolytic activities for FMS Fraction I, 
FMS Fraction II, and FHS Fraction III, in terms of umoles 
of FFA or glycerol released per 100 ug of FMS protein 
acting upon rat epididymal adipose tissue cell suspension 
for 3 hours at 37°C, are given in Table 22. For both 
indexes of lipolytic activity, FMS Fraction I and FMS Frac-
tion II contain the greatest degree in vitro specific lipo-
lytic activity. 
Polyacrylamide Gel Electrophoresis of FMS 
FMS Fraction I, FMS Fraction II, and FMS Fraction "III" 
(Fraction III plus pi 4.8 band) were examined for homogene-
·' 
TABLE 20 
Response of Adipocytes to FMS at the Initial 
and Final Stages of Purification 
No. of FFA 
(umoles/10 6 cells/hr)* 
Glycerol 
FMS** Determinations 
Control 6 200.76 X 10-3 + 0.01*** 31.26 X 10-3 + 0.000*** 
-
Crude 15 -3 215.08 X 10 + 0.01 -3 42.33 X 10 + 0.003 
-
Fraction I 5 609.77 X 10-3 + 0.01 183.91 X 10-3 + 0.001 
-
Fraction II 5 -3 621.89 X 10 + 0.01 182.74 X 10-3 + 0.001 
-
Fraction III 5 -3 611.73 X 10 + 0.01 182.93 X 10-3 + 0.000 
-
A Coulter electronic counter was used to count and size the suspended epidi-
dymal fat cells. Cell preparations were made only from rats weighing between 
130-150 gms. The mean diameter of the fat cells in this weight range, obtain-
ed by averaging the mean diameter from the separate cell suspensions used in 
the various assays, came to approximately 44u. 
* Micromoles of free fatty acids or glycerol released per 10 6 target cells by 
100 ug of test material acting on rat epididymal adipose tissue fat cells 
equivalent to, l gram of lipid in a medium of Krebs-Ringer phosphate buffer at 
37°c for '1 hr. 
** FMS material ~s described in Table 18. 
*** Mean + standard deviation. 
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TABLE 21 
Total Protein Content of 
FMS ?ractions I, II and III 
FMS Number of Determinations 
Fraction I 5 
Fraction II 5 
Fracti·on III 5 
* Mean + standard deviation. 
Percent 
Protein* 
59 + 5 
60 + 6 
100 + 2 
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TABLE 22 
Specific Lipolytic Activity of FMS Fraction I, 
FMS Fraction II, and FMS Fraction III Protein 
FFA* Glycerol* 
FHS Deteminations (umoles) (U.L1loles) 
Fraction I 5 52.88 + 0.71** 15.95 + 0.03** 
Fraction II 5 53.03 + 0.56 15.58 + 0.07 
Fraction II 5 31.30 + 0.74 9.36 + 0.01 
* Expressed as umoles FFA or glycerol released by 100 ug 
of FMS protein acting on rat epididymal adipose tissue 
cell suspension equivalent to 1 gram of lipid for 3 hours 
at .37°c. 
** Mean + standard deviation, five determinations. 
142 
ity by polyacrylamide gel electrophoresis. The results are 
photographically shown in Figure 12 and 13. Figure 12 re-
presents analysis with 250 micrograms of sample per gel. 
Figure 13 displays the 150 microgram sample gels of FMS 
Fraction I, II, and 11 III 11 whose staining intensities were 
subjected to quantitative densitometry with the Densicord 
Model 542 densitometer in conjunction with a Keuffel and 
Esser Model 620005 compensating polar planimeter. 
FMS Fraction I and FMS Fraction II separated into one 
major and one minor band. FMS Fraction 11 III 11 separated 
into two major and five minor bands. 
Figure 14, 15, and 16, show respectively, densitometer 
scans of FMS Fraction I, FMS Fraction II, and FMS Fraction 
"III 11 150 microgram sample gels. The 250 microgram sample 
gels were not subjected to quantitative densitometry due to 
broadened bands (overloaded bands) that distorted the pat-
tern on the densitometer tracing. 
The FMS Fraction I electrophoresed gel's slowest moving 
component, Component I, contained 97% of the total staining 
intensity, while Component II contained the remaining 3% 
(Figure 14). Identical quantitative staining intensity 
values were computed for the major and slmvest-moving band, 
Component I, and the minor band, Component II, present in 
the FMS Fraction II electrophoresed gel (Figure 15). 
The staining profile on the FMS Fraction "III 11 elec-
trophoresed gel revealed that two bands, Component II {40%) 
Figure 12: Polyacrylamide Gel Electrophoretic Patterns 
of (A) FMS Fraction II, (B) FMS Fraction III, 
and (C) FMS Fraction I, with 250 ug FMS Sam-
ple Application. Detection with fixative-
dye 20% TCA-Coomassie Brilliant Blue stain 
solution. 
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Figure 13. Polyacrylamide Gel Electrophoretic Patterns 
of (A) FMS Fraction II, (B) FMS Fraction III, 
and (C) FMS Fraction I, with 150 ug FMS Sam-
ple Application. Detection with fixative-dye 
20% TCA-Coomassie Brilliant Blue stain solution. 
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Figure 14. Chart Record of Percent Transmittance from Densicord Model 542 
Densitometer Scan of FMS Fraction I Electrophoresed Gel after 
Staining with Coomassie Blue. Quantitation revealed that com-
ponent I accounted for 97% of the staining profile and compo-
nent II 3%. 
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Figure 15. Chart Record of Percent Transmittance from Densicord Model 542 
Densitometer Scan of FMS Fraction II Electrophoresed Gel after 
Staining with Coomassie Blue. Quantitation revealed that com-
ponent I accounted for 97% of the staining profile and compo-
nent II 3%. 
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Figure 16. Chart Record of Percent Transmittance from Densicord Model 
542 Densitometer Scan of FMS Fraction "III" Electrophoresed 
Gel After Staining with Coomassie Blue. Quantitation reveal-
ed that component II (40%) and component V (36.7%) account 
for over three-fourths (76.7%) of the total staining profile. 
Components I, III, IV, VI, and VII comprise the remaining 
23.3%. 1-' ~ 
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and V (36.7%), accounted for over three-fourths of the total 
staining intensity. The various minor bands accounted for 
the remaining 23.3%: Component I, 0.6%; Component III, 4.4%; 
Component IV, 8.3%; Component VI, 8.5%; and Component VII, 
1.5%. 
The tracking dye band of Coomassie blue was allowed to 
migrate to a predetermined mark shown 75 em from the origin 
respective to the chart recording, to allow mobility measure-
ment comparison, upon alignment of the series of gels. 
Approximately the same distance of migration is observed for 
the one major and one minor band (FMS doublet) of FMS Frac-
tion I and II upon gel electrophoresis. 
CHAPTER IV 
DISCUSSION AND CONCLUSIONS 
A Fat Mobilizing Substance (FMS) shown to accelerate 
lipolysis of triglyceride in adipose tissue has_been iso-
lated from the urine of various mammalian species, includ-
ing man, during fasting and in other conditions associated 
with increased catabolism of fats (Chalmers et al., 1958, 
1960; Stevenson et al., 1964; Beaton et al., 1966; Pawan, 
1971}. 
FMS appears to be a polypeptide and is presumed to act 
by stimulating adenylate cyclase (Kwok, 1974). The precise 
chemical nature of this substance is not known, and to date, 
none of its physical characteristics have been reported. 
Progress in this area has been hampered by the fact that 
only milligram quantities have been obtained by current 
purification procedures, resulting in a lack of ready avail-
ability of purified material suitable for basic work. 
Numerous studies have shown that a loss of body fat 
results from a decrease in the size of adipose tissue cells. 
Injected FMS causes a mobilization and reduction of the body 
fat content (Chalmers et al., 1960; Kekwick and Pawan, 1968); 
hence, a reduction in the size of these fat cells. 
Urinary FMS is a reflection of the production of this 
substance in the body and its excretion by the kidneys. 
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Observations of higher mean urinary FMS levels in a group 
of non-obese as compared with the mean values in obese sub-
jects (Pawan, 1971) and that infant and young children ex-
creted more fat mobilizing activity then did young male 
adults during an 18 or 24 hour fast (Stevenson et al., 1965), 
together with the knowledge that adipose tissue relative to 
body weight increases with age and is markedly increased in 
the obese condition, suggest that FMS may be part of a phy-
siological homeostatic control of body fat with weight and 
age possibly bearing a relationship to the degree of FMS 
production and secretion. 
Accordingly, this study was concerned with obtaining 
further information relevant to the characterization of 
this lipolytic factor. The focus was directed to (1) de-
velopment of an assay system based on FMS-target cell inter-
action from fat cells of known size and lipid content, (2) 
introduction of a glycerol in vitro bioassay procedure as 
an index affording comparative criterion to the existing 
in vitro measurement of FFA release for the lipolytic 
response of FMS, (3) direction of attention towards the 
degree in which age and weight factors affect the quantity 
and quality of FMS urinary excretion, and (4) improvement 
of the efficiency of purification of this active principle. 
In the first part of this study, crude FMS was isolated 
according to the time-honored method involving benzoic acid 
precipitation of FMS from the urine of fasting rats, water 
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extraction, alcoholic precipitation, and lyophilization of 
the precipitate after redissolving in distilled water. 
Initially the colorimetric method developed by Duncombe 
(1964), as modified by Kwok (1974), was applied to determine 
the quantitative release of FFA from epididymal fat pads of 
the rat into the medium. This proved to be the most rapid 
and convenient method. 
Accurate comparative interpretation to previous works 
which express FMS lipolytic activity data in terms of 
release of FFA per 250 milligram rat epididymal fat pad 
being acted upon by 100 miprograms of FMS, rests upon the 
conditional state of the epididymal fat pads utilized within 
the assay system. Previous studies in our laboratory (Kwok, 
1974) utilized fasted rats which predisposes the tissue to 
a higher initial concentration of FFA. In this study, how-
ever tissue fragments were excised from epididymal fat pads 
of normal fed rats; hence a reasonable explanation, for the 
relatively higher control values in former studies of Kwok 
(1974) in comparison to those obtained in this study. The 
amount of FFA released into the medium is greater from adi-
pose tissue fragments excised from epididymal fat pads of 
fasted rats than from adipose tissue of normal fed rats. 
Although control lipolytic activity values were different 
in degree for each adipose tissue conditional state, the 
activity ratio of control/crude FMS was the same. Moreove4 
Beaton et al., (1966a) applying the same experimentaldesign 
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and mode of data expression and utilizing epididymal fat 
pads from normal fed rats, obtained similar values on 
control and crude FMS data to those obtained in this study. 
The increased sensitivity of isolated fat cells to 
lipolytic agents was demonstrated in this study by applying 
an assay system utilizing isolated fat cells to measure the 
lipolytic response of FMS. In addition, this method of 
assay provided an opportunity to study the lipolytic acti-
vity of FMS as a function of cell size, number and known 
lipid content. The Coulter electronic counter reliably 
measured the number of cells and provided the means to 
obtain the volume and diameter of the target cells. 
Thought was given to the cellular nature of the adi-
pose tissue to be employed within the assay systems, since 
it has become increasingly evident that differences in 
adipose tissue mass due to the number of the adipose cells 
in the tissue and the size of these adipocytes can have an 
effect on the metabolic activity of this tissue. 
Fat cell size in the rat increases throughout growth. 
Fat cells may lose their sensitivity to the lipolytic 
effects of FMS as they enlarge. In applying this ~oncept 
to the in vitro systems used in the various approaches to 
assay FMS, older rats of increased weight would have larger 
fat cells, which could be less sensitive to the lipolytic 
effects of FMS than the smaller fat cells from younger rats 
lesser in weight. Consequently, cell preparations were 
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made only from rats weighing between 130-150 grams. 
This study showed that the individually prepared cell 
suspensions obtained from each rat in. this particular 
weight range display a marked degree of intra-suspension 
heterogeneity, in adipocyte diameter and volume. Also 
displayed, was their marked degree in diameter and volume 
inter-suspension homogeneity. The mean cell diameter for 
any one cell suspension never deviated an entire micron 
from the experimentally determined mean of means cell dia-
meter of 44 u, with predictable, similar cell frequency 
distributions procured on all the independently prepared 
cell suspensions derived from different rat stock within 
this 130-150 gram weight range. Values on mean cell dia-
meter and volume determined within this study are in 
essential agreement with data published by other groups 
e.g., Livingston et al., 1974. Within this particular 
weight range the rat maintains a reliable and reproducible 
mean cell diameter and cell volume. 
Normal fed rats of the same weight range (130-150 
grams) were utilized in each and every approach employed in 
the testing of the various FMS preparations. Therefore, 
comparisons could be made between the cellular responsive-
ness of intact epididymal adipose tissue and that of iso-
lated fat cell suspensions to the lipolytic action of FMS. 
A sizeable increase in lipolytic activity was observed in 
all assays utilizing isolated fat cells significantly above 
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the activities obtained with the bioassays employing intact 
epididymal fat pads. 
In addition, to the quantitative release of FFA by 
FMS-target cells, the establishment in this study of gly-
cerol release as a reliable index of FMS lipolysis was 
initiated not only to remove the inherent problem of rely-
ing on only one criterion for in vitro measurement of FMS 
lipolytic activity, but to make it possible to draw certain 
inferences concerning changes in the rate of lipolysis and/ 
or reesterification. During lipolysis, glycerol is re-
leased and not metabolized to any significant extent. The 
free fatty acids can be activated and reesterified (Vaughan, 
1962). The relationship existing between the data obtained 
on these two parameters of lipolytic activity, shows no 
reesterification of the free fatty acid had taken place 
during FMS induced lipolysis in any of the in vitro bio-
assays performed for the testing of FMS lipolytic activity. 
Also, it can be affirmed that the glycerol released into 
the medium was produced from triglycerides and not by 
hydrolysis of a-glycerophosphate or fro~ smaller glycerides. 
Glycerol produced by hydrolysis of a-glycerophosphate or 
from lower glycerides would be associated with the forma-
tion of only 0 to 2 umoles of FFA per umole glycerol, 
instead of the 3 umoles per umole of glycerol produced 
from triglycerides observed in this study. 
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When the lipolytic activity elicited by FMS isolated 
from groups of male rats of variable weight and age was 
studied, it was found that an increase in weight and age 
was accompanied by a concomitant decrease in FMS specific 
activity and an increase in total activity. The lipolytic 
response of isolated adipocytes measured by their quanti-
tative release of FFA and glycerol was found to display 
a highly positive correlation to the release of FFA by 
epididymal fat pads in response to the lipolytic action of 
FMS. 
On the basis of FFA released per 250 milligram epidi-
dymal fat pad being acted upon for 3 hours at 37°C, a 
direct comparison to the results of Beaton et al. (1966) 
could be made. In essential agreement with Beaton, the 
greatest specific lipolytic activity was found in FMS iso-
lated from male rats weighing between 150-250 grams \'lith a 
mean age of 7 weeks. Beaton, in observing the specific 
activity excreted by 24 male rats at five different age 
intervals as they increased in age from 26 to 78 days, 
found that the greatest specific activity was excreted at 
50 days of age, 147 grams. 
In contrast to Beaton et al. (1966), total lipolytic 
activity was found to increase with increasing weight and 
age. For male rats weighing between 350-450 grams with a 
mean age of 18 weeks, the total activity nearly doubled 
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that excreted by male rats weighing between 150-250 grams 
at a mean age of 7 weeks. 
Beaton (1966) reported the greatest total lipolytic 
activity to be at 37 days of age (102 grams) with a non-
appreciable variance between 37, 50 and 62 days of age 
(102, 147, 197 grams). FMS excretion decreased markedly 
between 62 and 78 days of age (297 grams). 
A plausible explanation does exist for this signi-
ficant difference in total activity data between Beaton 
and the experimental findings of this thesis. This differ-
ence may be. the consequence of a difference in experimental 
protocol applied by Beaton et al. (1966) and that used in 
our laboratory. Beaton fasted 24 male rats at 26 days of 
age and subjected this Sru~e group of animals to the fast 
at 37, 50, 62, and 78 days of age. He employed neither a 
high fat diet nor a fast under cold stress as was applied 
in this experiment. In this current study, 11 different 
rat groups of 30 each were used to investigate the effects 
of weight and age on FMS excretion. 
More importantly, the current experimental protocol 
eliminated the recycling of the same test animals. In 
contrast to 11 different groups of rats being subjected to 
fast under cold stress on a one time basis, Beaton sub-
jected one groups of rats repeatedly to a fast at different 
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age intervals; this may have led to an exhaustion of the FMS 
supply available, or to a defect in FMS production in these 
animals. 
This possible explanation can be substantiated with 
use of other data published by Beaton et al. (1966) in the 
same report. When Beaton tested the effect of duration of 
fasting on excretion of FMS by the rat, he found a high 
total activity for rats weighing 270 grams during a 24 hour 
fast, when the rats were used on a one time basis; in con-
trast, he found a low total activity in rats 78 days in age 
(mean weight 297 grams) and fasted for 24 hours, rats that 
were repeatedly subjected·to this experimental condition~ 
Further, Beaton et al. (1966) in a study of ·the effect of 
the sex of the animal on FMS excretion showed a high total 
activity for male rats 90 days of age (mean weight 329 
grams), higher than any total activity reported at any age 
for the repeatedly used rats in his study of age effects on 
FMS excretion. 
Because of the small quantities of starting material 
available, each step in the attempted procedures for puri-
fication was assessed to determine the most suitable com-
bination of extraction, ultrafiltration, and gel filtration 
for the isolation of purer material. 
Some purification can be achieved by Diaflo ultrafil-
tration. The products of DM-5 ultrafiltration appear to 
produce retentates of higher specific activity and products 
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of higher yield in total activity than the preceding ultra-
filtration products of either PM-10 or UM-2 ultrafiltration. 
Also there are decreased losses in total activity when the 
DM-5 ultrafiltration is directly preceded by PM-10 ultra-
filtration as opposed to DM-5 ultrafiltration preceded by 
UM-2 ultrafiltration of the PM-10 filtrate. Consequently, 
it appears profitable to incorporate DM-5 ultrafiltration 
into existing FMS ultrafiltration purification protocol 
with the possible elimination of the UM-2 ultrafiltration 
step. 
Although Kekwick and Pawan (1967) and in our laboratory, 
Kwok (1974), have achieved further purification of their 
respective active ultrafiltration products by gel filtra-
tion through a column Sephadex G-50 directly followed by 
BioGel P-10, passage through both of these two functionally 
similar gel types appears not to be of necessity when the 
DM-5 residue is being further purified. It seems that DM-5 
ultrafiltration removes the same inactive material, con-
tained in the UM-2 residue and in the PM-10 filtrate, as 
does the Sephadex G-50 chromatographic column. This, 
suggests elimination of Sephadex G-50 gel filtration from 
the existing FMS purification protocol in dealing with the 
further purification of the DM-5 residue. 
It can be further deduced, that passage through both 
Sephadex G-50 and BioGel P-10 gel chromatography col~~s 
may not be essential for further UM-2 residue purification 
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by gel filtration. With the separation of the UM-2 residue 
into~an active and inactive peak fraction upon gel filtra-
tion by exclusive use of BieGel P-10, preparation of a 
Sephadex G-50 column to remove the same inactive material 
should be unnecessary. 
Relative to the DM-5 residue, a relatively small amount 
of,activity was present in the DM-5 filtrate. It now 
appears that the source of this activity is FMS Fraction III 
isolated from the isoelectric analysis of the UM-2 residue. 
FHS Fraction III in combination with non-lipolytic material 
is contained within the PM-10 filtrate and UM-2 residue but 
is removed by DM-5 ultrafiltration; and, as a consequence, 
appears to be found in the DM-5 filtrate. As shown on the 
UM-2 residue electrofocusing map, FMS Fraction III as con-
tained in the UM-2 residue is closely associated with non-
lipolytic material which could not be removed from FMS 
Fraction III when the UH-2 residue was directly subjected 
to isoelectric focusing without being previously purified 
by gel filtration. 
This inactive material along with FMS Fraction III is 
removed upon DM-5 ultrafiltration of either the PM-10 fil-
trate or UM-2 residue. Consequently, this inactive materi-
al, as well as FMS Fraction III, are still contained within 
the DM-5 filtrate. This seems in part to logically account 
for the relatively low specific lipolytic activity associ-
ated with the DM-5 filtrate. 
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The ease and convenience of DM-5 ultrafiltration in 
comparison to preparation of the Sephadex G-50 chromate-
graphic column, coupled with DM-5 ultrafiltration higher 
specific and total activity yields than PM-10 or UM-2 
ultrafiltration, suggest that DM-5 ultrafiltration of the 
PM-10 filtrate followed by gel filtration on BioGel P-10 to 
be'the most suitable combination of ultrafiltration and gel 
filtration for future purification of FMS Fraction I and 
FMS Fraction II. 
FMS Fraction III contained within the DM-5 filtrate, 
following DM-5 ultrafiltration of the PM-10 filtrate, must 
be further purified by either BioGel P-10 or Sephadex G-50 
before being subjected to electrofocusing under the current 
experimental protocol employed for isoelectric analysis. 
To obtain purified FMS Fraction III BioGel P-10 filtration 
would be the method of choice if no electrofocusing were to 
be carried out. Consequently, first, the DH-5 residue would 
be applied to the BioGel P-10 column, then, the DM-5 fil-
trate would be applied following the elution of FMS Frac-
tion I and FMS Fraction II. As experimentally shmvn, the 
DM-5 residue \'ITOuld produce one major elution peak contain-
ing both FMS Fraction I and F.HS Fraction II. In agreement 
with the UM-2 residue BioGel P-10 filtration, the DM-5 
filtrate would produce one activity peak (Fraction III) and 
an inactive peak fraction. 
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A limitation of ultrafiltration and gel filtration in 
the isolation and purification of FMS is the inability of 
gel filtration to separate FMS Fraction I from FMS Fraction 
II. Their isolation can be achieved by isoelectric focus-
ing of the DM-5 residue without prior gel filtration. Gel 
filtration may become obsolete for isolation of FMS Fraction 
III if a narrower ampholine range is used during isoelec-
tric analysis of the DM-5 filtrate. 
Obviously, ultimate proof of the best applicable 
purification route, rests in determination of FMS amino 
acid sequence, synthesis of a peptide with the proposed 
structure, and demonstration that the synthetic material 
has the full biological potency ascribed to FMS. 
In addition to serving as techniques for further 
purification of crude FMS, ultrafiltration and isoelectric 
focusing added to existing information on the approximate 
molec.ular weight of FMS. In agreement with Kwok (1974), 
UM-2 ultrafiltration of the PM-10 filtrate yielded a sub-
stance containing fat mobilizing activity with a molecular 
weight between 1,000 to 10,000 daltons. When this fat-
mobilizing material was further fractionated into substances 
greater than and less than 5,000 in molecular weight by use 
of the Diaflo ultrafiltration apparatus fitted with the 
newly patented DM-5 Diaflo membrane, subsequent, in vitro 
bioassay, revealed that the fraction with molecular weight 
greater than 5,000 possessed the greater fat mobilzing 
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activity. In accordance with the subsequent isolation of 
FMS Fraction I and FMS Fraction II upon resolution of the 
DM-5 residue on the electrofocusing ap9aratus, FHS Fraction 
I and FMS Fraction II, have to be between 5,000 and 10,000 
in molecular weight. 
Although :!"elative to the DM-5 residue, the 0::1-5 fil-
tr~te contained negligible lipolytic activity, it did con-
tain lipolytic activity similar in degree to that of crude 
FMS, thus indicating the presence of a lipolytically active 
fraction with a molecular weight between 1,000 and 5,000. 
In conjunction with the cumulative data obtained from 
the separate electrofocusing of DM-5 and the UM-2 residues, 
it appears that FMS Fraction III is contained within t~e 
DM-5 filtrate and has a QOlecular weight between 1,000 to 
5,000. Furthermore, present data, along with previous work 
done by other researchers and in our laboratory (Kt.;ok, 1974) 
seem to justify the conclusion that FMS Fraction III 
appears to be a dis-tinctive polype?tide of molecular weight 
to the upper range of an estimate a= 1,000 to 5,000 daltons. 
For example, in our laboratory K'tTOk, (1974) upon fractiona-
tion of UM-2 residue through Sephadex G-25, molecular weight 
range between 1,000 and 5,000, found the activity to be 
associated wit~ and initially after the void volume of the 
column. 
Isoelectric focusing, proved important as a separation 
technique in the isolation and further purification of FMS. 
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The lipolytically active principle as resolved on the elec-
trofocusing apparatus showed three active variants, namely: 
FMS Fraction I, FMS Fraction II, and FMS Fraction III. The 
structural difference between these ~hree FMS fractions that 
account for their resolution during electrofocusing were not 
established. 
As in other polypeptide hormones, the biological and 
immunological activities may reside in structural sub-enti-
ties that may be similar but may also differ in important 
structural details not yet clarified. Many highly purified 
proteins produce multiple bands, because of the presence of 
conformational isomers, isozymes, or partially filled sites 
for the essentially irreversible binding of metals, coenzymes 
and other small molecules. Such mechanisms may account for 
the microheterogeneity of FMS shown in the isoelectric 
separation of FMS Fraction I and FMS Fraction II. 
FMS Fraction I and FMS Fraction II are resolved on the 
electrofocusing apparatus as two distinct FMS variants, but 
are eluted as one major activity peak upon DM-5 or UM-2 
residue gel filtration on BioGel P-10 and upon UM-2 residue 
gel filtration on Sephadex G-50 directly followed by BioGel 
P-10. In addition, FMS Fraction I, and FMS Fraction II, 
are in the same, comparatively constricted, molecular weight 
range set by their identical fractionation properties upon 
ultrafiltration, display a non-significant difference in 
specific lipolytic activity and showed the same protein 
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content upon analysis. Furthermore, FMS I and FHS II 
displayed identical staining properties upon examination 
by gel electrophoresis. 
With respect to FMS Fraction III, the heterogeneity 
of FMS shown on the electrofocusing apparatus may reflect 
some change incurred prior to excretion or generated dur-
ing the isolation and purification of FMS. It might be 
argued that FMS Fraction III is identical to the first and 
second FNS Fractions with the non-protein component of FMS 
Fraction I and FMS Fraction II being removed from FMS Frac-
tion III. The hypothesis is supported by the results of 
protein analysis of the fractions. 
Electrofocusing yielded some data towards the estima-
tion of the isoelectric point (pi) of FMS Fraction I, II, 
and III. 
The pi (isoelectric point) values corresponding to 
FMS Fraction I and FMS Fraction II were respectively, pi 
4.1 and pi 4.5, in the preparative separation of DM-5 
residue or UM-2 residue. 
FMS Fraction III yielded a pi value of 5.1 in the 
resolution of UM-2 residue and of the active eluant peak 
fractions obtained from passage of FMS UM-2 residue through 
a Sephadex G-50-BioGel P-10 column. 
Upon analysis of the three FMS fractions by polyacryl-
amide gel electrophoresis and densitometric quantitation, 
no difference was detected between FMS Fraction I and FMS 
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Fraction II electrophoresed gels. The combination of the 
electrophoretic and molecular filtration effects resolved 
both FMS Fraction I and II into two discrete bands. FMS 
Fraction I contained one major and one small fast moving 
subsidiary band. This same doublet was also contained in 
FMS Fraction II. The two discrete bands exhibited identical 
staining intensity values and identical migration distances. 
A third active FMS fraction resolved in the isoelectric 
analysis of UM-2 residue was subjected to PAGE. As shown 
on the UM-2 residue electrofocusing map (Figure 9), FMS 
Fraction III, pi 5.1, and an inactive fraction, pi 4.8, 
comprise FMS Fraction "III". The degree of heterogeneity 
is unaccounted for. 
In favorable agreement with the results in this experi-
ment on PAGE, Kekwick and Pawan reported obtaining one 
major component peak, in the ultracentrifuge, with a small 
subsidary peak in testing the homogeneity of their partially 
purified FMS extract. This same extract gave a single band 
when subjected to PAGE. With reason, this single band 
migration on the polyacrylamide gels can be made subject 
to debate since the experimental conditions associated with 
their PAGE were not defined. The relative position, sharp-
ness, and intensity of minor bands can be easily affected 
by changes or differences in the conditions of PAGE: pH, 
buffer composition, ratio of acrylamide monomer to bis-
acrylamide, etc. 
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In contrast to the results on PAGE analysis of FMS 
found in this study, Kwok (1974}, in our laboratory, upon 
subjecting his purified FMS preparation (UM-2 residueSepha-
dex G-50 BieGel P-10 active eluant peak fraction} to PAGE, 
observed a single major protein band. However, the differ-
ence in results can be attributed to non-identical condi-
tions under which these PAGE analyses were performed. The 
results in this study were dependent upon an electrophoresis 
run for a longer period of time and gels that measured 10 ern 
in length as opposed to 6.5 ern. Also, the applied purified 
preparation was different in its source. The purification 
scheme applied in this study, may have removed or modified 
factors which previously interfered or did not allow full 
separation of FMS. 
It now appears that previous reports on isolation of 
FMS as a polypeptide molecule of assumingly single molecular 
form are somewhat premature. There is little doubt that 
this Fat-Mobilizing Substance, 'FMS', consists of three 
active variants representing three molecular forms which 
are presumably derivatives of the same protein molecule. 
It is recognized that the experiments in this study 
give less definitive answers regarding the nature of these 
three active variants than curiosity desires; however, it 
is hoped that they will draw attention on this subject of 
study and cause further experimentation by otherstorealize 
the full potential of FMS as possibly part of a physiologi-
cal homeostatic control of body fat. 
SUMNARY 
A Fat Mobilzing Substance (FHS) has been prepared 
from the urine of fasting rats by a four stage extraction 
procedure involving benzoic acid precipitation, water 
extraction, alcoholic precipitation and lyophilization. 
New approaches were established for testing the lipolytic 
activity of FMS in addition to the quantitative release of 
free fatty acids (FFA) from epididymal fat pads of the rat 
into a medium containing bovine serum albumin. To avoid 
misleading information on the metabolic potential of FMS. 
on its target tissue induced by differences in the cellu-
larity of the tissue amongst animals of different body 
weight, the cellular na·ture of the tissue employed within 
the assay systems was delineated. 
An assay system was instituted employing isolated fat 
cells and based upon the release of glycerol and FFA from 
fat cells of known size and lipid content. Fat cell pre-
parations were derived solely from rats 130-150 grams in 
weight and the mean cell diameter v1as found to be 44u + 10. 
The preparations demonstrated a marked degree of diameter 
and volume inter-suspension homogeneity. Therefore, data 
6 
wereexpressed in terms FFA released per 10 target cells 
and per unit cell lipid. Considerably increased lipolysis 
by FMS target cells was observed in all assays utilizing 
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isolated fat cells; this was reflected by the sizeable 
increased amounts of FFA released in response to the same 
FMS preparations initially tested employingintact fat pads 
from animals within the same weight range. 
For the purpose of removing the inherent problem of 
relying on only the one suspect parameter, FFA, as an index 
of FMS in vitro lipolysis glycerol release was introduced 
as a comparative criterion. The relationship existing 
between the two parameters showed no reesterification of 
the FFA had taken place during FMS induced lipolysis and 
affirmed that the glycerol released into the medium is pro-
duced from triglycerides and not primarily from glycerophos-
phates or lower glycerides. A highly positive correlation 
was demonstrated between the two methods of assay. 
When the lipolytic activity elicited by FMS isolated 
from variable weight range and age male rat groups was 
studied, it was found that an increase in weight and age 
was accompanied by a concomitant decrease in FMS specific 
activity and an increase in total activity. 
It now appears that previous reports on isolation of 
FMS as a polypeptide molecule of assumingly single molecular 
form are somewhat premature. Investigation of FMS with iso-
electric focusing revealed FMS consists of three active 
variants representing three molecular forms which are pre-
sumably derivatives of the same protein molecule, identifi-
ably: FMS Fraction I, pi 4.1; FMS Fraction II, pi 4.5; and 
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FMS Fraction III, pi 5.1. 
FMS Fraction I and II demonstrated identical staining 
properties upon densitometric quantitation of their poly-
acrylamide gels. FMS Fraction I resolved and separated 
into one major (97%) and one small (3%) fast moving subsi-
dary band. This same FMS doublet having identical staining 
·intensity values with identical migration distances-was 
also contained in FHS Fraction II. FHS Frac·tion II gels 
displayed an unaccounted for heterogeneity. 
FMS Fraction I and II appear to have molecular weights 
between 5,000 and 10,000 daltons, display no difference in 
specific lipolytic activity, and chemically show identical 
protein content (60%). FMS Fraction III yielded lower 
values of specific lipolytic activity per FMS protein and 
appears chemically to be a 100% polypeptide of a molecular 
weight to the upper range of an approximated molecular 
weight of 1,000 to 5,000 daltons. 
FMS Fraction I, II, and III were purified by ultra-
filtration and column chromatography and isoelectric focus-
ing. From this study, it is suggested that future purifi-
cations use the following scheme: (1) initial PM-10 ultra-
filtration of Crude FHS (2) DH-5 ultrafiltration of the PM-
10 filtrate, followed by (3a) gel filtration on BioGel P-10 
of the m1-5 residue to be the most sui table combination of 
ultrafiltration and gel filtration for future purification 
of FMS Fraction I and II, and (3b) gel filtration of the 
DM-5 ultrafiltrate should be the most suitable for FHS 
Fraction III. 
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A limitation of ultrafiltration and gel filtration in 
the isolation and purification of FMS is the inability of 
gel filtration to separate FMS Fraction I from FMS Fraction 
II. Their isolation can be achieved by isoelectric focusing 
of the DM-5 residue without prior gel filtration. 
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